Annotation,Domain ID,Annotation Members in Network,Annotation Members in Network Count,Summed Significance Score,Enrichment P-value,Enrichment Q-value,Depletion P-value,Depletion Q-value
'de novo' AMP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
'de novo' NAD biosynthetic process from tryptophan,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
'de novo' cotranslational protein folding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
'de novo' post-translational protein folding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
'de novo' protein folding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
'de novo' pyrimidine nucleobase biosynthetic process,21.0,CPA2;URA4;URA6,3.0,87.0,0.001,0.15108333333333335,1.0,1.0
(1->3)-beta-D-glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
(1->6)-beta-D-glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
2-micrometer plasmid partitioning,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
2-oxoglutarate metabolic process,31.0,KGD1;KGD2;LPD1,3.0,81.0,0.001,0.05332352941176471,1.0,1.0
5S class rRNA transcription by RNA polymerase III,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
7-methylguanosine RNA capping,6.0,CDC28;CEG1;CET1;KIN28;SPT4;STO1,6.0,123.0,0.001,0.1648181818181818,1.0,1.0
7-methylguanosine mRNA capping,6.0,CDC28;CEG1;CET1;KIN28;SPT4;STO1,6.0,123.0,0.001,0.1648181818181818,1.0,1.0
ADP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ADP metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
AMP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
AMP metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ATP export,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ATP transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Arp2/3 complex-mediated actin nucleation,43.0,ABP1;ARC15;ARC18;ARC19;ARC35;ARC40;ARP2;ARP3;LAS17;LSB1;MYO3;MYO5;PAN1;SLA1;SLA2;VRP1,16.0,42.0,0.001,0.0824090909090909,1.0,1.0
CAAX-box protein maturation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
CDP-diacylglycerol biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
COPII-coated vesicle budding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
COPII-coated vesicle cargo loading,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
CTP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
CUT metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Cvt vesicle assembly,58.0,ATG13;TRS85;VAC8,3.0,27.0,0.001,0.45325,1.0,1.0
D-ribose metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA amplification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA double-strand break attachment to nuclear envelope,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA double-strand break processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA duplex unwinding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA geometric change,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA protection,65.0,TSA1,1.0,15.552941247314493,0.006,0.5725263157894737,1.0,1.0
DNA replication checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA replication termination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"DNA replication, synthesis of RNA primer",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA replication-dependent chromatin assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA strand elongation,45.0,DPB4;MCM10;MCM2;MCM3;MCM4;MCM6;MCM7;POL1;POL2;PSF1;RFC1;RFC2;RFC3;RFC4;RFC5;TOP2,16.0,90.0,0.001,0.1648181818181818,1.0,1.0
DNA strand elongation involved in DNA replication,45.0,DPB4;MCM10;MCM2;MCM3;MCM4;MCM6;MCM7;POL1;POL2;PSF1;RFC1;RFC2;RFC3;RFC4;RFC5;TOP2,16.0,90.0,0.001,0.1648181818181818,1.0,1.0
DNA strand invasion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA synthesis involved in DNA repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA topological change,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA unwinding involved in DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA-templated DNA replication maintenance of fidelity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA-templated transcription open complex formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA-templated transcription termination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ER to Golgi ceramide transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ER-associated misfolded protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ER-dependent peroxisome organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ESCRT III complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
G protein-coupled receptor signaling pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
G1/S transition of mitotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
G2/M transition of mitotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
GMP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
GMP metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
GPI anchor biosynthetic process,5.0,CDC1;CWH43;DPM1;GAA1;GPI16;MCD4,6.0,126.0,0.001,0.03554901960784314,1.0,1.0
GPI anchor metabolic process,5.0,CDC1;CWH43;DPM1;GAA1;GPI16;MCD4,6.0,126.0,0.001,0.03554901960784314,1.0,1.0
GTP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
GTP metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi distribution to daughter cells,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi inheritance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi organization,10.0,ARF1;BOS1;COG1;COG3;EMP24;ERP1;ERP2;ERP4;ERV25;ERV29;HRR25;RET2;SEC16;SEC17;SEC18;SEC22;SEC8;SLY1;YIP1,19.0,117.0,0.001,0.1133125,1.0,1.0
Golgi to endosome transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi to plasma membrane protein transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi to plasma membrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi to vacuole transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi transport vesicle coating,55.0,GLO3,1.0,33.0,0.001,0.226625,1.0,1.0
Golgi vesicle budding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi vesicle docking,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
IMP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
IMP metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
IRE1-mediated unfolded protein response,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-alpha-amino acid transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-methionine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-methionine salvage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-methionine salvage from S-adenosylmethionine,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-methionine salvage from methylthioadenosine,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-proline biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-serine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-serine catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-serine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
MAPK cascade,33.0,AHK1;HOG1;HOS2;PBS2;SIF2;SNT1,6.0,60.0,0.001,0.10072222222222223,1.0,1.0
N-glycan processing,10.0,KTR3;MNN1,2.0,117.0,0.001,0.1133125,1.0,1.0
N-terminal peptidyl-methionine acetylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
N-terminal protein amino acid acetylation,16.0,ARD1;MDM20;NAT1;NAT5,4.0,81.0,0.001,0.226625,1.0,1.0
N-terminal protein amino acid modification,16.0,ARD1;MDM20;NAT1;NAT5,4.0,81.0,0.001,0.226625,1.0,1.0
NAD biosynthesis via nicotinamide riboside salvage pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NAD biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NAD catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NAD metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NAD-cap decapping,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NADH metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NADH oxidation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NADH regeneration,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NADP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NADP metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NADPH regeneration,34.0,ALD4;ALD6;GND1;SOL2;TAL1;TKL1,6.0,57.0,0.001,0.06475,1.0,1.0
NLS-bearing protein import into nucleus,75.0,KAP114;KAP123;KAP95;NAP1;NSP1;NUP145;NUP53;NUP57;NUP60;SRP1,10.0,18.0,0.001,0.13946153846153847,0.982,1.0
P-body assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA (guanine-N7)-methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA decapping,57.0,CDC36;DCP2;DCS1;DHH1;EAP1;EDC1;LSM1;MOT2;NOT3;NOT5;PAT1;RAI1;XRN1,13.0,27.0,0.001,0.259,0.988,1.0
RNA folding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA import into nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA polymerase I preinitiation complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA polymerase II core complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA polymerase II preinitiation complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA polymerase III assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA polymerase III preinitiation complex assembly,6.0,BDP1;BRF1;SPT15,3.0,123.0,0.001,0.1648181818181818,1.0,1.0
"RNA splicing, via endonucleolytic cleavage and ligation",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"RNA splicing, via transesterification reactions with guanosine as nucleophile",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA surveillance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Ras protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Rho protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
S-adenosylhomocysteine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
S-adenosylmethionine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
S-adenosylmethionine cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
S-adenosylmethionine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
SAGA complex localization to transcription regulatory region,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
SNARE complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
SNARE complex disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
SRP-dependent cotranslational protein targeting to membrane,65.0,KAR2;SEC61;SEC63;SEC65;SRP101;SRP14;SRP21;SRP54;SRP68;SRP72;SSA1;SSA2;SSA4;SSH1,14.0,21.0,0.001,0.1295,1.0,1.0
"SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"SRP-dependent cotranslational protein targeting to membrane, translocation",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
TOR signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
TORC1 signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
U1 snRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
U4 snRNA 3'-end processing,48.0,LRP1;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,11.0,63.99327749309441,0.001,0.06714814814814815,0.994,1.0
U5 snRNA 3'-end processing,48.0,LRP1;MTR4;RRP42;RRP43;RRP45;RRP6;SKI6,7.0,69.99327749309441,0.001,0.06714814814814815,1.0,1.0
UTP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
UV-damage excision repair,38.0,RSC2,1.0,48.880672491559835,0.006,0.8367692307692308,1.0,1.0
[2Fe-2S] cluster assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
acetate biosynthetic process,31.0,ALD4;ALD5;ALD6,3.0,81.0,0.001,0.05332352941176471,1.0,1.0
acetate metabolic process,31.0,ALD4;ALD5;ALD6,3.0,81.0,0.001,0.05332352941176471,1.0,1.0
acetate transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
acetyl-CoA biosynthetic process,31.0,LAT1;LPD1;PDA1;PDB1;PDX1,5.0,81.0,0.001,0.05332352941176471,1.0,1.0
acetyl-CoA metabolic process,31.0,KGD2;LAT1;LPD1;PDA1;PDB1;PDX1,6.0,81.0,0.001,0.05332352941176471,1.0,1.0
actin cortical patch assembly,43.0,ABP1;AKL1;END3;ENT1;ENT2;GID12;PAN1;SLA1;SLA2;SYP1,10.0,42.0,0.001,0.0824090909090909,1.0,1.0
actin cortical patch localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actin cortical patch organization,43.0,ABP1;AKL1;ARC15;ARC18;ARC19;ARC35;ARC40;ARP2;ARP3;END3;ENT1;ENT2;GID12;PAN1;SLA1;SLA2;SYP1;TWF1,18.0,31.105882494628986,0.006,0.3885,1.0,1.0
actin filament bundle organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actin filament depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actin filament polymerization,43.0,ABP1;AIM21;ARC15;ARC18;ARC19;ARC35;BNI1;CAP1;CAP2;LAS17;PFY1;SLA1;TDA2;TWF1,14.0,42.0,0.001,0.0824090909090909,1.0,1.0
actin filament severing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actin filament-based transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actin nucleation,43.0,ABP1;ARC15;ARC18;ARC19;ARC35;ARC40;ARP2;ARP3;BNI1;HOF1;LAS17;LSB1;MYO3;MYO5;PAN1;SLA1;SLA2;VRP1,18.0,42.0,0.001,0.0824090909090909,1.0,1.0
actin polymerization or depolymerization,43.0,ABP1;AIM21;ARC15;ARC18;ARC19;ARC35;BNI1;CAP1;CAP2;COF1;LAS17;PFY1;SLA1;TDA2;TWF1,15.0,42.0,0.001,0.0824090909090909,1.0,1.0
actomyosin contractile ring contraction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actomyosin contractile ring organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
acylglycerol catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
acylglycerol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adaptation of signaling pathway by response to pheromone involved in conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adenine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adenine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adenine nucleotide transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adenylate cyclase-modulating G protein-coupled receptor signaling pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adhesion between unicellular organisms,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aerobic electron transport chain,2.0,COX1;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8;CYT1;NDI1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1;SDH1,18.0,117.0,0.001,0.0824090909090909,0.964,1.0
agglutination involved in conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aggregation of unicellular organisms,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
alcohol catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aldehyde biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
alditol catabolic process,34.0,TPI1,1.0,42.21512624271077,0.006,0.3296363636363636,1.0,1.0
alditol metabolic process,34.0,GPP1;TCO89;TPI1,3.0,57.0,0.001,0.06475,1.0,1.0
alditol phosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aldonic acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
allantoin metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
alpha-amino acid catabolic process,31.0,ALT1;BNA4;CAR1;CHA1;EHD3;GLY1;ILV1;KGD2;LPD1;PDC1;PUT2;SAH1;SHM1;SHM2,14.0,81.0,0.001,0.05332352941176471,1.0,1.0
amide catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amide transport,42.0,DNF1;DNF2;NPR2;NVJ2;OSH3;SEC61;STE6;VHT1,8.0,48.66554624884907,0.001,0.20144444444444445,1.0,1.0
amine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amino acid activation,15.0,ARC1;CDC60;CRS1;DED81;DPS1;GLN4;GRS1;GUS1;HTS1;ILS1;KRS1;MES1;MSK1;NAM2;SES1;SLM5;THS1;TYS1;VAS1;YDR341C;YHR020W,21.0,84.0,0.001,0.20144444444444445,1.0,1.0
amino acid catabolic process to alcohol via Ehrlich pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amino acid catabolic process via Ehrlich pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amino acid import across plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amino acid transmembrane export from vacuole,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amino sugar biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amino sugar metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amino-acid betaine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aminoacyl-tRNA metabolism involved in translational fidelity,15.0,CDC60;ILS1;NAM2;VAS1;YHR020W,5.0,84.0,0.001,0.20144444444444445,1.0,1.0
aminoglycan metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aminophospholipid transport,42.0,DNF1;DNF2;DRS2;LEM3;MMM1,5.0,42.0,0.001,0.20144444444444445,1.0,1.0
anaerobic respiration,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
anaphase-promoting complex-dependent catabolic process,47.0,APC1;APC11;APC2;APC4;APC5;CDC16;CDC23;CDC26;CDC27;DOC1;MND2,11.0,26.662184995396274,0.006,0.6043333333333334,1.0,1.0
antisense RNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
antisense RNA transcript catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
apoptotic process,42.0,AIM14;BMH1;BMH2;CPR3;FYV10;HXK2;KEX1;NDI1;OYE2;PET9;POR1;STM1;TDH2;TDH3;TIM18,15.0,42.0,0.001,0.20144444444444445,1.0,1.0
arginine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
arginine catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
arginine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aromatic amino acid family biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aromatic amino acid family catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aromatic amino acid family catabolic process to alcohol via Ehrlich pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aromatic amino acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ascospore wall biogenesis,43.0,ACT1;ARP2;CHS3;CHS5;END3;GSC2;SWM1;YVH1,8.0,42.0,0.001,0.0824090909090909,1.0,1.0
ascospore-type prospore assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ascospore-type prospore membrane formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aspartate family amino acid catabolic process,31.0,CHA1;GLY1;ILV1;KGD2,4.0,81.0,0.001,0.05332352941176471,1.0,1.0
assembly of actomyosin apparatus involved in cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
assembly of actomyosin apparatus involved in mitotic cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
assembly of large subunit precursor of preribosome,79.0,DBP10;NIP7;NOG1;NOP2;RLP24;RPF2;SPB4;TIF6,8.0,147.0,0.001,0.36260000000000003,1.0,1.0
astral microtubule organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
asymmetric protein localization to old or new spindle pole body,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
attachment of meiotic spindle microtubules to kinetochore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
attachment of mitotic spindle microtubules to kinetochore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
attachment of spindle microtubules to kinetochore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
autophagosome maturation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
autophagosome-lysosome fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
autophagy of mitochondrion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
autophagy of peroxisome,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
axial cellular bud site selection,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
base-excision repair,38.0,APN1;POL2;STH1,3.0,66.0,0.001,0.259,1.0,1.0
"base-excision repair, gap-filling",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
basic amino acid transmembrane export from vacuole,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
basic amino acid transmembrane import into vacuole,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
basic amino acid transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
benzene-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
beta-glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
biogenic amine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
biogenic amine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
biological process involved in interspecies interaction between organisms,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
biological process involved in intraspecies interaction between organisms,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
bipolar cellular bud site selection,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
box C/D RNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
box C/D RNA metabolic process,64.0,NOP1;POP1;POP3;POP4;POP5;POP6;POP7;POP8;PXR1;RPP1;RPR2,11.0,21.0,0.001,0.36260000000000003,0.978,1.0
box C/D snoRNP assembly,59.0,HSC82;HSP82;PIH1;RVB1;RVB2,5.0,24.0,0.001,0.9065,1.0,1.0
box H/ACA RNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
box H/ACA snoRNP assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
branched-chain amino acid biosynthetic process,31.0,BAT1;BAT2;CHA1;HOM6;ILV1;ILV2;ILV3;ILV5;ILV6;LEU4;MMF1,11.0,81.0,0.001,0.05332352941176471,1.0,1.0
branched-chain amino acid catabolic process,31.0,BAT1;BAT2;EHD3;LPD1;PDC1,5.0,59.989916239641616,0.006,0.2529767441860465,1.0,1.0
branched-chain amino acid metabolic process,31.0,BAT1;BAT2;CHA1;EHD3;HOM6;ILV1;ILV2;ILV3;ILV5;ILV6;LEU4;LPD1;MMF1;PDC1,14.0,81.0,0.001,0.05332352941176471,1.0,1.0
budding cell apical bud growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
budding cell bud growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
calcineurin-mediated signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
calcium ion homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
calcium ion transmembrane import into cytosol,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
calcium ion transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
calcium ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
calcium-mediated signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
carbohydrate derivative transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
carbohydrate transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
carbon catabolite activation of transcription,29.0,ADR1;SNF5;SRB8;SSN2;SSN3;SSN8;SWI1;SWI3,8.0,63.0,0.001,0.259,1.0,1.0
carbon catabolite activation of transcription from RNA polymerase II promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
carbon catabolite regulation of transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
carbon catabolite regulation of transcription from RNA polymerase II promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
carbon catabolite repression of transcription,72.0,SPT6;TUP1;VPS36,3.0,13.331092497698137,0.006,0.4944545454545454,1.0,1.0
carbon catabolite repression of transcription from RNA polymerase II promoter by glucose,72.0,SPT6;TUP1;VPS36,3.0,13.331092497698137,0.006,0.4944545454545454,1.0,1.0
catabolite repression,72.0,SPT6;TUP1;VPS36,3.0,13.331092497698137,0.006,0.4944545454545454,1.0,1.0
cell adhesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell adhesion involved in single-species biofilm formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell cycle DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell morphogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell morphogenesis involved in conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell redox homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell wall (1->3)-beta-D-glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell wall assembly,43.0,ACT1;ARP2;CHS3;CHS5;END3;GSC2;SNF1;SWM1;YGP1;YVH1,10.0,42.0,0.001,0.0824090909090909,1.0,1.0
cell wall beta-glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell wall chitin biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell wall chitin metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell wall mannoprotein biosynthetic process,10.0,ANP1;HOC1;KTR1;KTR3;MNN10;MNN9;PSA1;VAN1,8.0,117.0,0.001,0.1133125,1.0,1.0
cell wall polysaccharide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell-cell adhesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell-substrate adhesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular aldehyde metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular bud neck septin ring organization,63.0,CDC11;SHS1,2.0,21.0,0.001,0.1133125,1.0,1.0
cellular bud site selection,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular detoxification of aldehyde,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular hyperosmotic response,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular lipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular metabolic compound salvage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular modified amino acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular modified amino acid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular modified amino acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular oxidant detoxification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to UV,38.0,RSC2,1.0,48.880672491559835,0.006,0.8367692307692308,1.0,1.0
cellular response to acid chemical,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to amino acid starvation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to amino acid stimulus,54.0,KOG1,1.0,24.440336245779918,0.006,0.9065000000000001,1.0,1.0
cellular response to anoxia,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to arsenic-containing substance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to carbohydrate stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to decreased oxygen levels,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to desiccation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to endogenous stimulus,75.0,DAL82;HRP1;KOG1;MLP1;NUP53,5.0,13.331092497698137,0.006,0.6398823529411765,1.0,1.0
cellular response to environmental stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to glucose starvation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to heat,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to inorganic substance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to light stimulus,38.0,RSC2,1.0,48.880672491559835,0.006,0.8367692307692308,1.0,1.0
cellular response to methylmercury,54.0,BOP3,1.0,33.0,0.001,0.6043333333333334,1.0,1.0
cellular response to misfolded protein,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to monosaccharide stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to nitrogen compound,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to nitrogen starvation,71.0,CCL1;KIN28,2.0,18.0,0.001,0.226625,1.0,1.0
cellular response to organonitrogen compound,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to osmotic stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to oxygen radical,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to oxygen-containing compound,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to phosphate starvation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to radiation,38.0,RSC2,1.0,48.880672491559835,0.006,0.8367692307692308,1.0,1.0
cellular response to reactive oxygen species,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to salt,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to toxic substance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to unfolded protein,5.0,HRD1;HSP60;IRE1;ISW1;KAR2;KIN2;PMT1;PMT2;PMT4;SPT20;YOS9;YPT1,12.0,126.0,0.001,0.03554901960784314,0.976,1.0
cellular response to water deprivation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to water stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to xenobiotic stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
centromere complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
centromere localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ceramide biosynthetic process,5.0,LAC1;LAG1;LCB1;LCB2;LIP1,5.0,126.0,0.001,0.03554901960784314,1.0,1.0
ceramide metabolic process,5.0,LAC1;LAG1;LCB1;LCB2;LIP1,5.0,126.0,0.001,0.03554901960784314,1.0,1.0
ceramide transport,42.0,DNF1;DNF2;NVJ2;OSH3,4.0,42.0,0.001,0.20144444444444445,1.0,1.0
chaperone cofactor-dependent protein refolding,65.0,HSP10;HSP104;KAR2;MDJ1;SIS1;SSA1;SSA2;SSA4;SSB1;SSB2;SSC1;SSQ1;SSZ1,13.0,21.0,0.001,0.1295,1.0,1.0
chaperone-mediated protein complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chaperone-mediated protein folding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chemotropism,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chloride transport,56.0,IST2,1.0,30.0,0.001,0.9065,1.0,1.0
chorismate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chromatin remodeling at centromere,38.0,SFH1;STH1;TOP2,3.0,66.0,0.001,0.259,1.0,1.0
chromosome attachment to the nuclear envelope,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chromosome condensation,53.0,HHO1;HMO1;RPD3;SIN3;SMC4;TOF2;YCG1,7.0,33.0,0.001,0.06475,1.0,1.0
chromosome localization to nuclear envelope involved in homologous chromosome segregation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chromosome organization involved in meiotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chromosome separation,47.0,APC11;APC5;CDC16;CDC23;CDC55;CTF19;CTF3;DSL1;GAC1;GLC7;MND2;SMC5;SMC6;TPD3;YCG1,15.0,36.0,0.001,0.13946153846153847,1.0,1.0
citrulline biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
clathrin coat assembly,43.0,SLA2,1.0,42.0,0.001,0.0824090909090909,1.0,1.0
clathrin coat disassembly,65.0,SSA1,1.0,15.552941247314493,0.006,0.5725263157894737,1.0,1.0
clathrin-coated vesicle cargo loading,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"clathrin-coated vesicle cargo loading, AP-1-mediated",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
clathrin-dependent endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",28.0,LAS1;RAI1;RPL17A;RPL17B;RPL37A;RPL37B;TOM1,7.0,63.0,0.001,1.0,1.0,1.0
cobalt ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
coenzyme A biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
coenzyme A metabolic process,5.0,CAB3;HMG1;HMG2;SIS2,4.0,126.0,0.001,0.03554901960784314,1.0,1.0
copper ion export,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
copper ion homeostasis,44.0,CCC2;HAA1;HHT1;HHT2;SOD1;TMN2,6.0,54.0,0.001,0.12086666666666668,1.0,1.0
copper ion import,56.0,FRE1;FRE4,2.0,22.21848749616356,0.006,1.0,1.0,1.0
copper ion transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
copper ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cotranslational protein targeting to membrane,65.0,BTT1;EGD1;EGD2;KAR2;SEC61;SEC63;SEC65;SRP101;SRP14;SRP21;SRP54;SRP68;SRP72;SSA1;SSA2;SSA4;SSH1,17.0,21.0,0.001,0.1295,1.0,1.0
cristae formation,1.0,ATP14;ATP20;MIC10;MIC19;MIC60;TIM11,6.0,116.65210123503789,0.001,0.9065,1.0,1.0
cyclic threonylcarbamoyladenosine biosynthetic process,2.0,TCD1;TCD2,2.0,117.0,0.001,0.0824090909090909,0.994,1.0
cysteine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cysteine biosynthetic process from serine,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cysteine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytochrome complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytogamy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytoplasm protein quality control,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytoplasm protein quality control by the ubiquitin-proteasome system,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytoplasmic microtubule organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytoplasmic translational elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytoplasmic translational initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytoskeleton-dependent intracellular transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytosolic ribosome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
dTMP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
deadenylation-dependent decapping of nuclear-transcribed mRNA,57.0,CDC36;DCP2;DCS1;DHH1;EAP1;EDC1;LSM1;NOT3;NOT5;PAT1,10.0,27.0,0.001,0.259,0.994,1.0
deadenylation-independent decapping of nuclear-transcribed mRNA,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
deoxyribonucleoside monophosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
deoxyribonucleotide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
dephosphorylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
detection of chemical stimulus,65.0,SIS1,1.0,15.552941247314493,0.006,0.5725263157894737,1.0,1.0
detoxification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
dicarboxylic acid biosynthetic process,31.0,AAT2;ARO3;BNA4;FOL2;GDH1;IDH1;IDH2;IDP1;MIS1;PUT2,10.0,81.0,0.001,0.05332352941176471,1.0,1.0
dicarboxylic acid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
dicarboxylic acid metabolic process,31.0,AAT2;ARO3;BNA4;FOL2;FUM1;GDH1;HOM3;IDH1;IDH2;IDP1;KGD1;KGD2;LPD1;MDH1;MDH2;MIS1;PCS60;PUT2;SHM1;SHM2,20.0,81.0,0.001,0.05332352941176471,1.0,1.0
dicarboxylic acid transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
diol biosynthetic process,5.0,FOL2;LCB1;LCB2;LCB5;MCO14;TIM54,6.0,126.0,0.001,0.03554901960784314,0.994,1.0
diphosphoinositol polyphosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
disaccharide catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
disaccharide metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
division septum assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
dolichol-linked oligosaccharide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
donor selection,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
double-strand break repair via break-induced replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
double-strand break repair via nonhomologous end joining,38.0,CDC28;IRC20;POL2;RSC1;RSC2;RSC30;RSC8;SIN3;SIR2;SIR3,10.0,66.0,0.001,0.259,1.0,1.0
double-strand break repair via synthesis-dependent strand annealing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
early endosome to Golgi transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
eisosome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endocytic recycling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",49.0,BUD21;BUD23;DBP8;DIP2;EMG1;ENP1;ESF2;FCF1;FCF2;KRR1;LCP5;LOC1;MPP10;MRD1;NOC4;NOP14;NOP58;PNO1;PWP2;RCL1;ROK1;RPS0A;RPS0B;RPS18A;RPS18B;RPS21A;RPS21B;RRP5;RRP9;RRS1;SAS10;TOM1;UTP10;UTP11;UTP13;UTP14;UTP18;UTP20;UTP23;UTP6;UTP7,41.0,80.88739499846542,0.001,0.36260000000000003,1.0,1.0
"endonucleolytic cleavage in ITS1 upstream of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",17.0,RPS0A;RPS0B;RPS21A;RPS21B;TSR1,5.0,93.0,0.001,0.45325,1.0,1.0
"endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",49.0,BMS1;BUD21;DBP8;DIP2;EMG1;ESF2;FCF1;FCF2;LOC1;MPP10;MRD1;NOC4;NOP14;NOP58;PNO1;PWP2;RCL1;ROK1;RRP5;RRP9;SAS10;TOM1;UTP10;UTP11;UTP13;UTP14;UTP18;UTP20;UTP23;UTP6;UTP7,31.0,72.0,0.001,0.36260000000000003,0.994,1.0
endoplasmic reticulum inheritance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum membrane fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum membrane organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum polarization,63.0,SCS2;SHS1,2.0,21.0,0.001,0.1133125,1.0,1.0
endoplasmic reticulum tubular network maintenance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum tubular network organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum unfolded protein response,5.0,HRD1;IRE1;ISW1;KAR2;KIN2;PMT1;PMT2;PMT4;SPT20;YOS9;YPT1,11.0,126.0,0.001,0.03554901960784314,0.976,1.0
endoplasmic reticulum-plasma membrane tethering,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endosomal vesicle fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endosome organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endosome to plasma membrane protein transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"energy coupled proton transmembrane transport, against electrochemical gradient",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
energy reserve metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
enzyme-directed rRNA pseudouridine synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
error-prone translesion synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of chromosome localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of mitochondrion localization,43.0,AIM21;ARC18;ARP2;MDM10,4.0,42.0,0.001,0.0824090909090909,1.0,1.0
establishment of mitotic sister chromatid cohesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of mitotic spindle localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of mitotic spindle orientation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein localization to chromosome,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein localization to endoplasmic reticulum,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein localization to endoplasmic reticulum membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein localization to extracellular region,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein localization to mitochondrial membrane,15.0,MDM10;MMM1;OXA1;SAM35;TIM18;TIM54;TOM22;TOM70,8.0,84.0,0.001,0.20144444444444445,1.0,1.0
establishment of protein localization to peroxisome,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein localization to plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein-containing complex localization to telomere,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of sister chromatid cohesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of spindle localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment or maintenance of actin cytoskeleton polarity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment or maintenance of cytoskeleton polarity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ethanol catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ethanol metabolic process,31.0,ALD4;ALD5;ALD6;PDC1,4.0,81.0,0.001,0.05332352941176471,1.0,1.0
ether metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
exit from mitosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
exocyst assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
exocyst localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
exocytic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
exonucleolytic catabolism of deadenylated mRNA,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",48.0,CSL4;DIS3;LRP1;MPP6;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,14.0,63.99327749309441,0.001,0.06714814814814815,0.988,1.0
"exonucleolytic trimming to generate mature 5'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",35.0,BRX1;RLP7,2.0,53.32436999079255,0.006,1.0,1.0,1.0
export across plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
facultative heterochromatin formation,53.0,ADA2;CTI6;DEP1;ESA1;ISW2;NET1;PAF1;PHO23;PNC1;RPD3;RXT2;SAP30;SDS3;SIN3;SIR2;TOF2,16.0,33.0,0.001,0.06475,1.0,1.0
fatty acid alpha-oxidation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid beta-oxidation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid beta-oxidation using acyl-CoA dehydrogenase,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid biosynthetic process,5.0,ACP1;ELO3;ETR1;FAS1;IFA38;OLE1;TSC13,7.0,100.71348036422557,0.004,0.13946153846153847,1.0,1.0
fatty acid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid derivative metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid oxidation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fermentation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
folic acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
folic acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
folic acid-containing compound biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
folic acid-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
formation of cytoplasmic translation initiation complex,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
formation of translation preinitiation complex,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
formin-nucleated actin cable organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"fructose 1,6-bisphosphate metabolic process",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fructose 6-phosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fructose metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fructose transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fumarate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fungal-type cell wall (1->3)-beta-D-glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fungal-type cell wall assembly,43.0,ACT1;ARP2;CHS3;CHS5;END3;GSC2;SNF1;SWM1;YVH1,9.0,42.0,0.001,0.0824090909090909,1.0,1.0
fungal-type cell wall beta-glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fungal-type cell wall chitin biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fungal-type cell wall polysaccharide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
gamma-tubulin complex localization to mitotic spindle pole body,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
gene conversion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
generation of catalytic spliceosome for first transesterification step,26.0,IST3;PRP19;PRP2;SNU114;SPP381;SYF1;YJU2,7.0,133.5462187404089,0.001,0.259,1.0,1.0
generation of catalytic spliceosome for second transesterification step,26.0,CDC40;CEF1;ISY1;PRP16;PRP45;PRP8;SLU7;YJU2,8.0,153.0,0.001,0.259,1.0,1.0
global genome nucleotide-excision repair,44.0,HHT1;HHT2;PAF1;RTF1,4.0,54.0,0.001,0.12086666666666668,1.0,1.0
glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glucan catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glucosamine-containing compound biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glucosamine-containing compound catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glucosamine-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glucose 6-phosphate metabolic process,34.0,GND1;HXK1;HXK2;PGI1;SOL2;TAL1;TKL1,7.0,60.0,0.001,0.06475,1.0,1.0
glucose mediated signaling pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glucose transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glutamate biosynthetic process,31.0,GDH1;IDH1;IDH2;IDP1;PUT2,5.0,81.0,0.001,0.05332352941176471,1.0,1.0
glutamate metabolic process,31.0,GDH1;IDH1;IDH2;IDP1;PUT2,5.0,81.0,0.001,0.05332352941176471,1.0,1.0
glutamine family amino acid biosynthetic process,31.0,CPA2;GDH1;GLN1;IDH1;IDH2;IDP1;PRO2;PRO3;PUT2,9.0,81.0,0.001,0.05332352941176471,1.0,1.0
glutamine family amino acid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glutamine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glutathione catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glutathione metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glyceraldehyde-3-phosphate metabolic process,34.0,TAL1;TPI1,2.0,57.0,0.001,0.06475,1.0,1.0
glycerol biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycerol catabolic process,34.0,TPI1,1.0,42.21512624271077,0.006,0.3296363636363636,1.0,1.0
glycerol metabolic process,34.0,GPP1;TCO89;TPI1,3.0,57.0,0.001,0.06475,1.0,1.0
glycerol transmembrane transport,21.0,RGC1,1.0,87.0,0.001,0.15108333333333335,1.0,1.0
glycerol-3-phosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycerolipid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycerophospholipid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycogen biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycogen catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycogen metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycolipid biosynthetic process,5.0,CDC1;CWH43;DPM1;GAA1;GPI16;MCD4,6.0,126.0,0.001,0.03554901960784314,1.0,1.0
glycolytic fermentation to ethanol,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycoprotein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycosyl compound biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycosyl compound catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycosyl compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glyoxylate cycle,21.0,IDP1;MLS1,2.0,64.43361373887433,0.006,0.6043333333333334,1.0,1.0
glyoxylate metabolic process,21.0,IDP1;MLS1,2.0,64.43361373887433,0.006,0.6043333333333334,1.0,1.0
heme transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
heteroduplex formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
hexose biosynthetic process,34.0,FBA1;FYV10;GID7;GID8;GPM1;MDH2;PGI1;PGK1;PYC1;PYC2;RMD5;SNF1;SNF4;TDH1;TDH2;TDH3;TPI1;TSA1;VID24;VID28;VID30,21.0,57.0,0.001,0.06475,0.97,1.0
hexose catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
histidine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
histone catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
histone mRNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
histone modification,14.0,ADA2;SUS1,2.0,84.0,0.001,0.36260000000000003,1.0,1.0
homocysteine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
homologous chromosome pairing at meiosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
homologous chromosome segregation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
homoserine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
homoserine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
hydrogen peroxide catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
hydrogen peroxide metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
hydrogen sulfide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
hyperosmotic response,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
import across plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inclusion body assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
indole-containing compound biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
indole-containing compound catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
indole-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inner mitochondrial membrane organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inorganic anion transmembrane transport,9.0,IST2;MIR1;OAC1;PHO87;PHO90;PHO91;SYG1,7.0,75.54285748695611,0.006,0.6043333333333334,1.0,1.0
inorganic anion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inorganic cation import across plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inositol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inositol phosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inositol phosphoceramide metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
integrated stress response signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intein-mediated protein splicing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intermembrane lipid transfer,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
internal protein amino acid acetylation,14.0,ADA2,1.0,84.0,0.001,0.36260000000000003,1.0,1.0
interstrand cross-link repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intra-Golgi vesicle-mediated transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular calcium ion homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular copper ion homeostasis,44.0,HAA1;HHT1;HHT2;SOD1;TMN2,5.0,54.0,0.001,0.12086666666666668,1.0,1.0
intracellular distribution of mitochondria,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular glucose homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular lipid transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular mRNA localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular magnesium ion homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular manganese ion homeostasis,10.0,GDT1;PMR1;SMF3;SPF1,4.0,117.0,0.001,0.1133125,1.0,1.0
intracellular nitrogen homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular pH reduction,9.0,PFK2;RAV1;RAV2;RRG1;SKP1;STV1;VMA1;VMA10;VMA11;VMA13;VMA2;VMA4;VMA5;VMA6;VMA7;VMA8;VPH1;VPS3,18.0,102.0,0.001,0.12086666666666668,1.0,1.0
intracellular protein transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular sphingolipid homeostasis,42.0,GNP1,1.0,31.105882494628986,0.006,0.777,1.0,1.0
intracellular sterol transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular zinc ion homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intralumenal vesicle formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intron homing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
iron coordination entity transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
iron import into cell,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
iron ion transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
iron ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
isoleucine biosynthetic process,31.0,BAT1;BAT2;CHA1;HOM6;ILV1;ILV2;ILV3;ILV5;ILV6;MMF1,10.0,81.0,0.001,0.05332352941176471,1.0,1.0
isoleucine metabolic process,31.0,BAT1;BAT2;CHA1;HOM6;ILV1;ILV2;ILV3;ILV5;ILV6;LPD1;MMF1,11.0,81.0,0.001,0.05332352941176471,1.0,1.0
isoprenoid biosynthetic process,5.0,HMG1;HMG2,2.0,126.0,0.001,0.03554901960784314,1.0,1.0
isoprenoid metabolic process,5.0,ALG9;DPM1;HMG1;HMG2;OST1,5.0,126.0,0.001,0.03554901960784314,1.0,1.0
karyogamy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
karyogamy involved in conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
kinetochore assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
kinetochore organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
kynurenine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lactate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lactate catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lactate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lagging strand elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
leading strand elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
leucine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
leucine catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
leucine metabolic process,31.0,BAT1;BAT2;LEU4;LPD1,4.0,59.989916239641616,0.006,0.2529767441860465,1.0,1.0
lipid droplet formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lipid droplet organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lipid homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lipid modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lipid storage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lipid translocation,42.0,DNF1;DNF2;DRS2;LEM3;YPK1,5.0,42.0,0.001,0.20144444444444445,1.0,1.0
lipoate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lipoprotein biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
liposaccharide metabolic process,5.0,CDC1;CWH43;DPM1;GAA1;GPI16;MCD4,6.0,126.0,0.001,0.03554901960784314,1.0,1.0
long-chain fatty acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
long-chain fatty acid import into cell,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
long-chain fatty acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
long-chain fatty acid transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lysine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lysine biosynthetic process via aminoadipic acid,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lysine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA 3'-splice site recognition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA 5'-splice site recognition,23.0,PRP39;PRP42;PRP8;PRP9;YHC1,5.0,75.0,0.001,0.20144444444444445,1.0,1.0
mRNA branch site recognition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"mRNA cis splicing, via spliceosome",26.0,CBC2;CLF1;CWC15;PRP21;PRP39;PRP40;PRP42;PRP8;PRP9;SNU66;YHC1,11.0,153.0,0.001,0.259,1.0,1.0
mRNA export from nucleus in response to heat stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA polyadenylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA pseudouridine synthesis,76.0,CBF5;PUS4,2.0,13.331092497698137,0.006,1.0,1.0,1.0
mRNA splice site recognition,26.0,CDC40;ISY1;LUC7;NAM8;PRP39;PRP42;PRP8;PRP9;YHC1,9.0,157.4436974992327,0.001,0.259,1.0,1.0
mRNA stabilization,81.0,ATP25,1.0,64.43361373887433,0.006,1.0,1.0,1.0
maintenance of DNA repeat elements,70.0,CSM3;CTF18;CTF8;DCC1;ORC1;PBP1;SEM1;TOF1,8.0,18.0,0.001,0.20144444444444445,1.0,1.0
maintenance of DNA trinucleotide repeats,70.0,CTF18;CTF8;DCC1;SEM1,4.0,18.0,0.001,0.20144444444444445,1.0,1.0
maintenance of RNA location,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maintenance of cell polarity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maintenance of location in cell,10.0,BRE5;EMP24;EPS1;ERD2;ERP1;ERP2;ERP4;PEP8;PFY1;RER1;SDS22;TWF1;UBP3;VPS1;VPS15;VPS27;VPS35;VPS36;WTM1,19.0,117.0,0.001,0.1133125,1.0,1.0
maintenance of mitotic sister chromatid cohesion,70.0,DCC1,1.0,13.331092497698137,0.006,0.9889090909090908,1.0,1.0
maintenance of protein localization in endoplasmic reticulum,10.0,EMP24;EPS1;ERD2;ERP1;ERP2;ERP4;RER1,7.0,117.0,0.001,0.1133125,1.0,1.0
maintenance of protein localization in organelle,10.0,EMP24;EPS1;ERD2;ERP1;ERP2;ERP4;RER1;SDS22;WTM1,9.0,117.0,0.001,0.1133125,1.0,1.0
maintenance of protein location,10.0,BRE5;EMP24;EPS1;ERD2;ERP1;ERP2;ERP4;PEP8;PFY1;RER1;SDS22;TWF1;UBP3;VPS1;VPS15;VPS27;VPS35;VPS36;WTM1,19.0,117.0,0.001,0.1133125,1.0,1.0
maintenance of protein location in cell,10.0,BRE5;EMP24;EPS1;ERD2;ERP1;ERP2;ERP4;PEP8;PFY1;RER1;SDS22;TWF1;UBP3;VPS1;VPS15;VPS27;VPS35;VPS36;WTM1,19.0,117.0,0.001,0.1133125,1.0,1.0
maintenance of protein location in nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maintenance of rDNA,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maintenance of sister chromatid cohesion,70.0,DCC1,1.0,13.331092497698137,0.006,0.9889090909090908,1.0,1.0
maintenance of transcriptional fidelity during transcription elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maintenance of translational fidelity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
malate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
manganese ion transport,10.0,GDT1;PMR1;SMF3,3.0,117.0,0.001,0.1133125,1.0,1.0
mannan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mannose metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mannose transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mannosylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mating type determination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mating type switching,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maturation of 5S rRNA,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiosis II cell cycle process,41.0,RDH54,1.0,31.105882494628986,0.006,1.0,1.0,1.0
meiotic DNA double-strand break formation,69.0,BRE1;MCM21;RTF1;SET1;SPP1;SWD3;YCG1,7.0,18.0,0.001,0.9065,1.0,1.0
meiotic DNA double-strand break processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic cell cycle checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic cell cycle phase transition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic chromosome condensation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic chromosome separation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic gene conversion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic mismatch repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic recombination checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic sister chromatid segregation,41.0,RDH54,1.0,31.105882494628986,0.006,1.0,1.0,1.0
meiotic spindle assembly checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic spindle disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic spindle organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
membrane addition at site of cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
membrane assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
membrane biogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
metallo-sulfur cluster assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
metaphase/anaphase transition of mitotic cell cycle,47.0,APC1;APC11;APC2;APC5;CDC16;CDC23;CDC27;CDC55;CTF19;CTF3;DSL1;GAC1;GLC7;MND2;SDS24;SWM1;TPD3,17.0,36.0,0.001,0.13946153846153847,1.0,1.0
methionine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
methionine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
methylguanosine-cap decapping,57.0,CDC36;DCP2;DCS1;DHH1;EAP1;EDC1;LSM1;MOT2;NOT3;NOT5;PAT1;RAI1,12.0,27.0,0.001,0.259,0.994,1.0
microlipophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microtubule depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microtubule nucleation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microtubule organizing center localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microtubule organizing center organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microtubule polymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microtubule polymerization or depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microtubule-based movement,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
misfolded protein transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mismatch repair,44.0,HSM3;MSH3;RFC1;RFC2;RFC3,5.0,54.0,0.001,0.12086666666666668,1.0,1.0
mitochondria-associated ubiquitin-dependent protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial ATP synthesis coupled electron transport,2.0,COX1;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8;CYT1;NDI1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1;SDH1,18.0,117.0,0.001,0.0824090909090909,0.964,1.0
mitochondrial ATP transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial DNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial RNA 5'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial RNA catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial RNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial RNA processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial cytochrome c oxidase assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"mitochondrial electron transport, cytochrome c to oxygen",2.0,COX1;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8,8.0,117.0,0.001,0.0824090909090909,0.994,1.0
"mitochondrial electron transport, succinate to ubiquinone",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"mitochondrial electron transport, ubiquinol to cytochrome c",2.0,CYT1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1,8.0,117.0,0.001,0.0824090909090909,0.976,1.0
mitochondrial fission,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial genome maintenance,31.0,ABF2;ACO1;CCE1;CCM1;GEP5;GGC1;HSP60;HSP78;ILV5;MDJ1;MDM10;MDV1;MGM101;MHR1;MMM1;MRPL51;PIM1;RIM1;RPO41;RRG1;RRG8;RRG9;YHM2,23.0,81.0,0.001,0.05332352941176471,1.0,1.0
mitochondrial outer membrane translocase complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial phosphate ion transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial protein processing,2.0,AFG3;COR1;CYM1;YTA12,4.0,117.0,0.001,0.0824090909090909,0.994,1.0
mitochondrial proton-transporting ATP synthase complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial respirasome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial respiratory chain complex III assembly,2.0,QCR7;QCR9,2.0,117.0,0.001,0.0824090909090909,0.994,1.0
mitochondrial respiratory chain complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial ribosome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial tRNA 5'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial tRNA modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial tRNA processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial tRNA thio-modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial translational elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial translational initiation,80.0,AIM23;IFM1;MRP21;MRP51;RSM28,5.0,78.0,0.001,1.0,1.0,1.0
mitochondrial transmembrane transport,2.0,AFG3;FSF1;MGE1;MTM1;SSC1;TIM23;TIM50;TOM20;TOM22;TOM40;TOM70;XDJ1;YME1;ZIM17,14.0,95.65210123503789,0.001,0.45325000000000004,1.0,1.0
mitochondrion distribution,43.0,ABF2;ARC15;ARP2;BUL1;CLU1;MDM20;MDM32;OLE1;PHB1;PHB2,10.0,42.0,0.001,0.0824090909090909,1.0,1.0
mitochondrion inheritance,43.0,ABF2;ARC15;ARP2;BUL1;MDM20;MDM32;OLE1;PHB1;PHB2,9.0,42.0,0.001,0.0824090909090909,1.0,1.0
mitochondrion localization,43.0,ABF2;AIM21;ARC15;ARC18;ARP2;BUL1;CLU1;MDM10;MDM20;MDM32;OLE1;PHB1;PHB2,13.0,42.0,0.001,0.0824090909090909,1.0,1.0
mitochondrion morphogenesis,2.0,PHB1,1.0,117.0,0.001,0.0824090909090909,1.0,1.0
mitochondrion-endoplasmic reticulum membrane tethering,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic DNA damage checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic DNA integrity checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic DNA replication checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic DNA replication initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic DNA replication preinitiation complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic G1/S transition checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic G2/M transition checkpoint,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic actomyosin contractile ring contraction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic actomyosin contractile ring disassembly,47.0,APC2,1.0,26.662184995396274,0.006,0.6043333333333334,1.0,1.0
mitotic chromosome condensation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic cytokinetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic division septum assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic intra-S DNA damage checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic morphogenesis checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic sister chromatid biorientation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic sister chromatid cohesion,70.0,CSM3;CTF18;CTF19;CTF3;CTF4;CTF8;DCC1;ELG1;GPN3;MCM21;MCM22;NAT5;NPA3;POL2;TOF1,15.0,18.0,0.001,0.20144444444444445,1.0,1.0
mitotic spindle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic spindle checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic spindle disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic spindle elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic spindle formation (spindle phase one),-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic spindle organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic spindle orientation checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
monoatomic anion transport,56.0,IST2;POR1,2.0,30.0,0.001,0.9065,1.0,1.0
monocarboxylic acid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
monocarboxylic acid transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
monosaccharide biosynthetic process,34.0,FBA1;FYV10;GID7;GID8;GPM1;MDH2;PGI1;PGK1;PYC1;PYC2;RMD5;SNF1;SNF4;TDH1;TDH2;TDH3;TPI1;TSA1;VID24;VID28;VID30,21.0,57.0,0.001,0.06475,0.97,1.0
monosaccharide catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
monosaccharide transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ncRNA catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ncRNA export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of ATP-dependent activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of Arp2/3 complex-mediated actin nucleation,43.0,LSB1;SLA1;SLA2,3.0,42.0,0.001,0.0824090909090909,1.0,1.0
negative regulation of DNA amplification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA recombination,6.0,CDC73;HHO1;HST1;PAF1;RPD3;SET2;SIR2,7.0,123.0,0.001,0.1648181818181818,1.0,1.0
negative regulation of DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA replication origin binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA-templated DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA-templated DNA replication initiation,47.0,CDC16;RIF1,2.0,26.662184995396274,0.006,0.6043333333333334,1.0,1.0
"negative regulation of DNA-templated transcription, elongation",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of G1/S transition of mitotic cell cycle,53.0,ASH1;BRE1,2.0,24.440336245779918,0.006,0.35090322580645167,1.0,1.0
negative regulation of G2/M transition of mitotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of Ras protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of Rho protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of TORC1 signaling,68.0,IML1;NPR2;NPR3;PBP1,4.0,18.0,0.001,0.10664705882352941,1.0,1.0
negative regulation of actin filament bundle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of actin filament depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of actin filament polymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of actin nucleation,43.0,HOF1;LSB1;SLA1;SLA2,4.0,42.0,0.001,0.0824090909090909,1.0,1.0
negative regulation of antisense RNA transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of apoptotic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of autophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of autophagy of mitochondrion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of carbohydrate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of cell cycle G2/M phase transition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of cell cycle checkpoint,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of cell division,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of cellular catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of chromosome organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of clathrin-dependent endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of cytoplasmic mRNA processing body assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of cytoplasmic translation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of cytoskeleton organization,43.0,ABP1;AIM21;BNI1;CAP1;CAP2;CDC28;EFB1;HOF1;LSB1;MHP1;PFY1;SLA1;SLA2;TDA2;TWF1,15.0,31.105882494628986,0.006,0.3885,1.0,1.0
negative regulation of developmental process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of double-strand break repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of double-strand break repair via nonhomologous end joining,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of endoplasmic reticulum unfolded protein response,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of establishment of protein localization,5.0,SCS2;SPC2;STE24,3.0,126.0,0.001,0.03554901960784314,0.994,1.0
negative regulation of exit from mitosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of filamentous growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of formin-nucleated actin cable assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of gluconeogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of glucose mediated signaling pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of growth of unicellular organism as a thread of attached cells,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of heterochromatin organization,53.0,BDF1;BDF2;CTI6;DEP1;PHO23;RPD3;RXT2;SAP30;SDS3;SIN3;WTM1;WTM2,12.0,33.0,0.001,0.06475,1.0,1.0
negative regulation of intracellular signal transduction,68.0,BCY1;BEM2;GPB2;IML1;IRA1;MND2;NET1;NPR2;NPR3;PBP1;SAC7;TOF2,12.0,18.0,0.001,0.10664705882352941,1.0,1.0
negative regulation of intracellular transport,5.0,ISW1;SCS2;SPC2;STE24,4.0,126.0,0.001,0.03554901960784314,0.994,1.0
negative regulation of invasive growth in response to glucose limitation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of lipid biosynthetic process,54.0,GTS1;MOT3;SEI1;YPK1,4.0,24.440336245779918,0.006,0.9065000000000001,1.0,1.0
negative regulation of lipid metabolic process,54.0,GTS1;MOT3;SEI1;YPK1,4.0,24.440336245779918,0.006,0.9065000000000001,1.0,1.0
negative regulation of mRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mRNA catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mRNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mRNA processing,62.0,NAB2;RPL30,2.0,15.552941247314493,0.006,1.0,1.0,1.0
negative regulation of macroautophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of meiotic DNA double-strand break formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of meiotic cell cycle,33.0,CDC28;DSL1;FPR3;HOS2;PDR16;RPD3;SET2;SET3;SIF2,9.0,60.0,0.001,0.10072222222222223,1.0,1.0
negative regulation of meiotic cell cycle phase transition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of meiotic nuclear division,33.0,FPR3;HOS2;RPD3;SET2;SET3;SIF2,6.0,60.0,0.001,0.10072222222222223,1.0,1.0
negative regulation of metaphase/anaphase transition of cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of metaphase/anaphase transition of meiotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of microtubule depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of microtubule polymerization or depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mitochondrion organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mitophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mitotic cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mitotic recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mitotic spindle assembly checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of molecular function,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of nuclear division,33.0,CDC55;CTF19;CTF3;DSL1;FPR3;GAC1;GLC7;HOS2;MND2;RPD3;SET2;SET3;SIF2;TPD3,14.0,44.43697499232712,0.006,0.5725263157894737,1.0,1.0
"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of nucleocytoplasmic transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of organelle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of phosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of phosphatidylinositol biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of phospholipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of phospholipid translocation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of phosphorus metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of phosphorylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"negative regulation of post-translational protein targeting to membrane, translocation",5.0,SPC2;STE24,2.0,126.0,0.001,0.03554901960784314,1.0,1.0
negative regulation of programmed cell death,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of proteasomal protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of proteasomal ubiquitin-dependent protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein import into nucleus during spindle assembly checkpoint,75.0,MLP1,1.0,13.331092497698137,0.006,0.6398823529411765,1.0,1.0
negative regulation of protein kinase C signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein localization,5.0,SCS2;SPC2;STE24,3.0,126.0,0.001,0.03554901960784314,0.994,1.0
negative regulation of protein localization to nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein modification by small protein conjugation or removal,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein modification process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein phosphorylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein polymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein-containing complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein-containing complex disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of proteolysis,2.0,MND2;PHB1;PHB2;UBP6,4.0,117.0,0.001,0.0824090909090909,1.0,1.0
negative regulation of proteolysis involved in protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of pseudohyphal growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of rDNA heterochromatin formation,53.0,CTI6;DEP1;PHO23;RPD3;RXT2;SAP30;SDS3;SIN3,8.0,33.0,0.001,0.06475,1.0,1.0
negative regulation of reciprocal meiotic recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of reproductive process,33.0,AKR1;CDC28;DSL1;FPR3;HOS2;MCM21;PDR16;RPD3;SET2;SET3;SIF2;YCG1,12.0,60.0,0.001,0.10072222222222223,1.0,1.0
negative regulation of ribosomal protein gene transcription by RNA polymerase II,29.0,SRB2,1.0,46.65882374194348,0.006,0.9889090909090908,1.0,1.0
negative regulation of septation initiation signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of sexual sporulation resulting in formation of a cellular spore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of silent mating-type cassette heterochromatin formation,53.0,CTI6;DEP1;PHO23;RPD3;RXT2;SAP30;SDS3;SIN3;WTM1;WTM2,10.0,33.0,0.001,0.06475,1.0,1.0
negative regulation of sister chromatid cohesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of small GTPase mediated signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of small molecule metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of sphingolipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of sporulation resulting in formation of a cellular spore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of supramolecular fiber organization,43.0,ABP1;AIM21;BNI1;CAP1;CAP2;EFB1;HOF1;LSB1;MHP1;PFY1;SLA1;SLA2;TDA2;TWF1,14.0,31.105882494628986,0.006,0.3885,1.0,1.0
negative regulation of telomere maintenance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of telomere maintenance via telomere lengthening,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of termination of DNA-templated transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of transcription by RNA polymerase I,53.0,CDC14;PHO23;RIO1;RPD3;RXT3;SAP30;SIN3;SPT4;SPT5;UME1,10.0,33.0,0.001,0.06475,1.0,1.0
negative regulation of transcription by RNA polymerase III,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of transcription by transcription factor localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of transcription regulatory region DNA binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of translation in response to stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of translational elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of translational frameshifting,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of translational initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of translational initiation in response to stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of transmembrane transport,5.0,SPC2;STE24,2.0,126.0,0.001,0.03554901960784314,1.0,1.0
negative regulation of transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of ubiquitin-dependent protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
neutral amino acid transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
neutral lipid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
neutral lipid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nicotinamide nucleotide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nicotinamide riboside metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nicotinate nucleotide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nitrate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nitrogen catabolite activation of transcription from RNA polymerase II promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nitrogen catabolite regulation of transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nitrogen catabolite regulation of transcription from RNA polymerase II promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nitrogen cycle metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nonfunctional rRNA decay,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear RNA surveillance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear cell cycle DNA replication initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear mRNA surveillance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear mRNA surveillance of mRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear migration by microtubule mediated pushing forces,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear migration involved in conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear polyadenylation-dependent CUT catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear polyadenylation-dependent antisense transcript catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear polyadenylation-dependent mRNA catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear polyadenylation-dependent ncRNA catabolic process,48.0,AIR2;CSL4;DIS3;LRP1;MPP6;MTR3;MTR4;RAI1;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,16.0,63.99327749309441,0.001,0.06714814814814815,0.982,1.0
nuclear polyadenylation-dependent rRNA catabolic process,48.0,AIR2;CSL4;DIS3;LRP1;MPP6;MTR3;MTR4;RAI1;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6,15.0,63.99327749309441,0.001,0.06714814814814815,0.982,1.0
nuclear polyadenylation-dependent snoRNA catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear polyadenylation-dependent tRNA catabolic process,48.0,AIR2;CSL4;DIS3;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,13.0,63.99327749309441,0.001,0.06714814814814815,0.982,1.0
nuclear pore complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear pore localization,75.0,NUP120;NUP133;NUP145;NUP84;NUP85;SEC13,6.0,18.0,0.001,0.13946153846153847,1.0,1.0
nuclear pore organization,75.0,DYN2;KAP95;NDC1;NIC96;NUP157;NUP170;NUP188;NUP53;NUP57;POM152;POM34;RTN1;SNL1;YOP1,14.0,18.0,0.001,0.13946153846153847,0.994,1.0
nuclear protein quality control by the ubiquitin-proteasome system,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, RNase MRP-dependent",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, exonucleolytic",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, no-go decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, non-stop decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",23.0,CBC2;CDC33;DBP2;DCP2;ECM32;EDC1;HRP1;NMD2;PUB1;SKI2;SKI3;SKI6;SKI7;STO1;UPF3;XRN1,16.0,55.546218740408904,0.006,0.777,1.0,1.0
nuclear-transcribed mRNA poly(A) tail shortening,57.0,CCR4;CDC36;CDC39;NOT3;NOT5;PAB1;PAN2;POP2;RPB7;VTS1,10.0,30.66554624884907,0.001,0.36260000000000003,0.994,1.0
nucleic acid phosphodiester bond hydrolysis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleobase biosynthetic process,21.0,ADE3;ADE57;CPA2;MTD1;URA4;URA6;URA7,7.0,87.0,0.001,0.15108333333333335,1.0,1.0
nucleobase metabolic process,21.0,ADE3;ADE57;CPA2;MTD1;PHM8;URA4;URA6;URA7,8.0,64.43361373887433,0.006,0.6043333333333334,1.0,1.0
nucleobase-containing small molecule catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleolar chromatin organization,53.0,ADA2;CTI6;DEP1;ESA1;HMO1;ISW2;NET1;PAF1;PHO23;PNC1;RPD3;RXT2;SAP30;SDS3;SIN3;SIR2;SMC4;TOF2;YCG1,19.0,33.0,0.001,0.06475,1.0,1.0
nucleolar large rRNA transcription by RNA polymerase I,6.0,BUD27;CDC73;CTR9;HPR1;LEO1;MOT1;PAF1;RPA12;RPA135;RPA14;RPA190;RPA34;RPA43;RPA49;RRN10;RRN9;RTF1;SPT15;SPT4;SPT5,20.0,123.0,0.001,0.1648181818181818,1.0,1.0
nucleolus organization,53.0,ADA2;CTI6;DEP1;ESA1;HMO1;ISW2;NET1;PAF1;PHO23;PNC1;RPD3;RXT2;SAP30;SDS3;SIN3;SIR2;SMC4;TOF2;YCG1,19.0,33.0,0.001,0.06475,1.0,1.0
nucleophagy,53.0,ATG13;CDC48;HMO1;OSH3;RPD3;SIN3;TRS85;VAC8;VAM6;VPS33;VPS41,11.0,33.0,0.001,0.06475,1.0,1.0
nucleoside diphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleoside diphosphate catabolic process,34.0,CDC19;ENO1;ENO2;FBA1;GDA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,18.0,60.0,0.001,0.06475,1.0,1.0
nucleoside diphosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleoside metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleoside monophosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleoside monophosphate phosphorylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleoside phosphate catabolic process,34.0,CDC19;ENO1;ENO2;FBA1;GDA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;PHM8;TDH1;TDH2;TDH3;TPI1,19.0,59.221848749616356,0.001,0.06475,1.0,1.0
nucleoside triphosphate biosynthetic process,2.0,ADK2;ATP1;ATP14;ATP15;ATP16;ATP17;ATP18;ATP19;ATP2;ATP20;ATP3;ATP4;ATP5;ATP6;ATP7;CDC21;CPA2;IMD3;IMD4;TIM11;URA7;URK1;VMA1;YNK1,24.0,117.0,0.001,0.0824090909090909,1.0,1.0
nucleosome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleosome disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleosome organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleotide catabolic process,34.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;PHM8;TDH1;TDH2;TDH3;TPI1,18.0,59.221848749616356,0.001,0.06475,1.0,1.0
nucleotide salvage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleotide transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nucleotide-excision repair, DNA gap filling",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleotide-sugar biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleotide-sugar metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleus localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
olefinic compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
oligopeptide transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
oligosaccharide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
oligosaccharide catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
oligosaccharide-lipid intermediate biosynthetic process,5.0,ALG2;ALG9;DPM1;OST1,4.0,126.0,0.001,0.03554901960784314,1.0,1.0
one-carbon compound transport,68.0,NPR2,1.0,18.0,0.001,0.10664705882352941,1.0,1.0
one-carbon metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
organelle localization by membrane tethering,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
organelle transport along microtubule,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
organic cation transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
organic hydroxy compound catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
organic hydroxy compound transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ornithine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
osmosensory signaling MAPK cascade,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
osmosensory signaling pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
osmosensory signaling pathway via Sho1 osmosensor,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
outer mitochondrial membrane organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
oxidative phosphorylation,2.0,ATP15;ATP2;ATP5;COX1;COX12;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8;CYT1;NDI1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1;SDH1,22.0,117.0,0.001,0.0824090909090909,0.958,1.0
pentose catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pentose metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pentose-phosphate shunt,34.0,GND1;SOL2;TAL1;TKL1,4.0,57.0,0.001,0.06475,1.0,1.0
"pentose-phosphate shunt, non-oxidative branch",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peptide catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peptide mating pheromone maturation involved in positive regulation of conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peptide pheromone maturation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peptidyl-histidine modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peptidyl-lysine methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peptidyl-lysine modification,55.0,ADA2;KAP95;KRE29;NSE3;NUP53;NUP60;PSE1;RKM4;SMC5;SMC6,10.0,33.0,0.001,0.226625,1.0,1.0
peptidyl-lysine monomethylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peroxisomal membrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peroxisome fission,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peroxisome inheritance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phenol-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphate ion transmembrane transport,9.0,MIR1;PHO87;PHO90;PHO91;SYG1,5.0,75.54285748695611,0.006,0.6043333333333334,1.0,1.0
phosphate ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidic acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylcholine acyl-chain remodeling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylcholine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylcholine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylglycerol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylinositol dephosphorylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylinositol phosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylinositol-3-phosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylinositol-mediated signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylserine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phospholipid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phospholipid dephosphorylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phospholipid translocation,42.0,DNF1;DNF2;DRS2;LEM3;YPK1,5.0,42.0,0.001,0.20144444444444445,1.0,1.0
phospholipid transport,42.0,DNF1;DNF2;DRS2;LEM3;MDM10;MMM1;NVJ2;PDR16;YPK1,9.0,42.0,0.001,0.20144444444444445,1.0,1.0
phytosteroid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
piecemeal microautophagy of the nucleus,58.0,ATG13;CDC48;OSH3;TRS85;VAC8;VAM6;VPS33;VPS41,8.0,19.996638746547205,0.006,1.0,1.0,1.0
plasma membrane organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
plasma membrane selenite transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
plasma membrane tubulation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
plasmid maintenance,64.0,KIP1;SNM1,2.0,15.552941247314493,0.006,1.0,0.988,1.0
plasmid partitioning,64.0,KIP1;SNM1,2.0,15.552941247314493,0.006,1.0,0.988,1.0
poly(A)+ mRNA export from nucleus,75.0,DBP5;ENP1;GBP2;MEX67;MLP1;MTR2;NAB2;NEW1;NIC96;NSP1;NUP133;NUP145;NUP60;SPN1;SPT6;SSL2;SUS1;THO1,18.0,22.443697499232712,0.001,0.13946153846153847,1.0,1.0
polyadenylation-dependent RNA catabolic process,48.0,AIR2;CSL4;DIS3;LRP1;MPP6;MTR3;MTR4;RAI1;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,16.0,63.99327749309441,0.001,0.06714814814814815,0.982,1.0
polyadenylation-dependent snoRNA 3'-end processing,48.0,LRP1;MTR3;MTR4;RRP4;RRP40;RRP46;RRP6;SKI6,8.0,86.88739499846542,0.001,0.06714814814814815,1.0,1.0
polyol biosynthetic process,5.0,FOL2;GPP1;LCB1;LCB2;LCB5;MCO14;TIM54,7.0,126.0,0.001,0.03554901960784314,0.994,1.0
polyol catabolic process,34.0,TPI1,1.0,42.21512624271077,0.006,0.3296363636363636,1.0,1.0
polyol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
polyol transmembrane transport,21.0,RGC1,1.0,87.0,0.001,0.15108333333333335,1.0,1.0
polyphosphate biosynthetic process,9.0,VTC1;VTC4;VTC5,3.0,102.0,0.001,0.12086666666666668,1.0,1.0
polyphosphate metabolic process,9.0,PHO87;PHO90;PHO91;VPH1;VTC1;VTC2;VTC3;VTC4;VTC5,9.0,102.0,0.001,0.12086666666666668,1.0,1.0
polyprenol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
polysaccharide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
polysaccharide catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of ATP-dependent activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of Arp2/3 complex-mediated actin nucleation,43.0,ABP1;ARC40;LAS17;MYO3;MYO5;PAN1;VRP1,7.0,31.105882494628986,0.006,0.3885,1.0,1.0
positive regulation of Atg1/ULK1 kinase complex assembly,71.0,CCL1;KIN28,2.0,18.0,0.001,0.226625,1.0,1.0
positive regulation of DNA binding,72.0,SPT6;SUA7,2.0,18.0,0.001,0.13946153846153847,1.0,1.0
positive regulation of DNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of DNA recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of DNA replication origin binding,72.0,SPT6,1.0,18.0,0.001,0.13946153846153847,1.0,1.0
positive regulation of DNA-templated DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of DNA-templated DNA replication initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of DNA-templated transcription initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of G1/S transition of mitotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of G2/M transition of mitotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of MAPK cascade,33.0,AHK1;HOS2;PBS2;SIF2;SNT1,5.0,60.0,0.001,0.10072222222222223,1.0,1.0
positive regulation of RNA binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of RNA polymerase II transcription preinitiation complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of RNA splicing,23.0,NAM8,1.0,55.546218740408904,0.006,0.777,1.0,1.0
positive regulation of SNARE complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of TOR signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of TORC1 signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of actin filament bundle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of actin filament depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of actin nucleation,43.0,ABP1;ARC40;LAS17;MYO3;MYO5;PAN1;VRP1,7.0,31.105882494628986,0.006,0.3885,1.0,1.0
positive regulation of attachment of spindle microtubules to kinetochore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of autophagosome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of autophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of carbohydrate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of catalytic activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cell adhesion involved in single-species biofilm formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cell communication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cell cycle checkpoint,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cell cycle phase transition,47.0,APC11;APC5;CCR4;CDC16;CDC23;CDC25;CDC55;CYS4;GID8;GLC7;MND2;NUD1;SDA1;XRN1;ZDS1,15.0,36.0,0.001,0.13946153846153847,1.0,1.0
positive regulation of cell division,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cell growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cellular response to amino acid starvation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cellular response to drug,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cellular response to heat,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of chromosome organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of chromosome segregation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of clathrin-dependent endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"positive regulation of cytokinesis, actomyosin contractile ring assembly",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cytoplasmic mRNA processing body assembly,54.0,CAF20,1.0,24.440336245779918,0.006,0.9065000000000001,1.0,1.0
positive regulation of cytoskeleton organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of developmental process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of double-strand break repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of double-strand break repair via homologous recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of endodeoxyribonuclease activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of endoplasmic reticulum unfolded protein response,54.0,KIN2,1.0,22.0,0.01,0.9459130434782609,1.0,1.0
positive regulation of establishment of protein localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of exit from mitosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of filamentous growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of filamentous growth of a population of unicellular organisms,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of filamentous growth of a population of unicellular organisms in response to starvation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of formation of translation preinitiation complex,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of formin-nucleated actin cable assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of gluconeogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of glucose metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of glycerol transport,21.0,RGC1,1.0,87.0,0.001,0.15108333333333335,1.0,1.0
positive regulation of growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of growth of unicellular organism as a thread of attached cells,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of hydrolase activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of intracellular protein transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of intracellular signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of intracellular transport,17.0,POR1;RIO2,2.0,68.87731123810704,0.006,1.0,1.0,1.0
positive regulation of invasive growth in response to glucose limitation,53.0,GAL11;PHO23;RXT2;SAP30;SNF2;SNF5;YTA7,7.0,33.0,0.001,0.06475,1.0,1.0
positive regulation of lipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of lipid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of lipid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mRNA processing,23.0,NAM8,1.0,55.546218740408904,0.006,0.777,1.0,1.0
"positive regulation of mRNA splicing, via spliceosome",23.0,NAM8,1.0,55.546218740408904,0.006,0.777,1.0,1.0
positive regulation of macroautophagy,68.0,CDC14;CDC55;EPL1;ESA1;FAR11;IML1;NPR2;NPR3;PIK1;PPH21;PPH22;RPD3;RTC1;SNF1;TRS33;YVH1,16.0,18.0,0.001,0.10664705882352941,1.0,1.0
positive regulation of mating type switching,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of meiotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of meiotic nuclear division,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of metaphase/anaphase transition of cell cycle,47.0,APC11;APC5;CDC16;CDC23;MND2,5.0,36.0,0.001,0.13946153846153847,1.0,1.0
positive regulation of microtubule polymerization or depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mitochondrial DNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mitochondrial fission,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mitochondrial fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mitochondrion organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mitotic actomyosin contractile ring disassembly,47.0,APC2,1.0,26.662184995396274,0.006,0.6043333333333334,1.0,1.0
positive regulation of mitotic cell cycle,47.0,APC11;APC5;CCR4;CDC16;CDC23;CDC25;CDC28;CDC55;CYS4;GID8;GLC7;MND2;NUD1;SDA1;XRN1;ZDS1,16.0,36.0,0.001,0.13946153846153847,1.0,1.0
positive regulation of mitotic cell cycle phase transition,47.0,APC11;APC5;CCR4;CDC16;CDC23;CDC25;CDC55;CYS4;GID8;GLC7;MND2;NUD1;SDA1;XRN1;ZDS1,15.0,36.0,0.001,0.13946153846153847,1.0,1.0
positive regulation of mitotic cytokinetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mitotic spindle pole body separation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of molecular function,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of monoatomic ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of nuclear cell cycle DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of nuclear division,47.0,APC11;APC5;CDC16;CDC23;CPR1;MND2;SWI6,7.0,36.0,0.001,0.13946153846153847,1.0,1.0
"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of nuclease activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of nucleocytoplasmic transport,17.0,POR1;RIO2,2.0,68.87731123810704,0.006,1.0,1.0,1.0
positive regulation of organelle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of phosphorus metabolic process,63.0,ASC1;CDC11;CDC12;RPP1B;VAC14,5.0,21.0,0.001,0.1133125,1.0,1.0
positive regulation of phosphorylation,63.0,ASC1;CDC11;CDC12;RPP1B;VAC14,5.0,21.0,0.001,0.1133125,1.0,1.0
positive regulation of programmed cell death,21.0,NDI1,1.0,64.43361373887433,0.006,0.6043333333333334,1.0,1.0
positive regulation of protein autoubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein catabolic process,12.0,RPT1;RPT2;RPT3;RPT4;RPT5;RPT6,6.0,96.0,0.001,0.09542105263157895,1.0,1.0
positive regulation of protein import into nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein localization to nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein modification by small protein conjugation or removal,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein modification process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein phosphorylation,63.0,ASC1;CDC11;CDC12;RPP1B,4.0,21.0,0.001,0.1133125,1.0,1.0
positive regulation of protein ubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein-containing complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein-containing complex disassembly,15.0,ANB1;HYP2;TWF1,3.0,62.21176498925797,0.006,0.8367692307692308,1.0,1.0
positive regulation of proteolysis,12.0,RPT1;RPT2;RPT3;RPT4;RPT5;RPT6,6.0,96.0,0.001,0.09542105263157895,1.0,1.0
positive regulation of proteolysis involved in protein catabolic process,12.0,RPT1;RPT2;RPT3;RPT4;RPT5;RPT6,6.0,96.0,0.001,0.09542105263157895,1.0,1.0
positive regulation of pseudohyphal growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of pseudohyphal growth by positive regulation of transcription from RNA polymerase II promoter,53.0,ASH1;SFH1,2.0,24.440336245779918,0.006,0.35090322580645167,1.0,1.0
positive regulation of rRNA processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of receptor internalization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of receptor-mediated endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of reproductive process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of response to extracellular stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of ribosomal protein gene transcription by RNA polymerase II,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of secretion by cell,54.0,KIN2,1.0,22.0,0.01,0.9459130434782609,1.0,1.0
positive regulation of signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of small molecule metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of stress-activated protein kinase signaling cascade,33.0,HOS2;SIF2;SNT1,3.0,60.0,0.001,0.10072222222222223,1.0,1.0
positive regulation of supramolecular fiber organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of telomere maintenance via telomere lengthening,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of transcription by RNA polymerase I,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of transcription by RNA polymerase III,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of transcription by galactose,29.0,SRB8;SSN2;SSN3;SSN8,4.0,63.0,0.001,0.259,1.0,1.0
positive regulation of transcription elongation by RNA polymerase I,6.0,BUD27;CDC73;CTR9;HPR1;LEO1;PAF1;RTF1;SPT4;SPT5,9.0,91.0957987342706,0.006,0.777,1.0,1.0
positive regulation of transcription elongation by RNA polymerase II,72.0,ASF1;CAF130;CAF40;CCR4;CDC36;CDC39;CDC73;CET1;ESA1;GCN5;GIM5;KIN28;LEO1;MOT2;NAP1;NOT3;NOT5;NPL3;PAF1;PDP3;PFD1;POP2;RPT4;RPT6;RSC6;RTF1;SPT4;SPT5;SPT6;TFG1;VPS15;XRN1;YKE2,33.0,18.0,0.001,0.13946153846153847,1.0,1.0
positive regulation of transcription from RNA polymerase II promoter by galactose,29.0,SSN2;SSN3,2.0,63.0,0.001,0.259,1.0,1.0
positive regulation of transcription from RNA polymerase II promoter by oleic acid,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of transcription initiation by RNA polymerase II,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of transcription regulatory region DNA binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of transferase activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of translation in response to stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of translational elongation,15.0,ANB1;EFT1;EFT2;HYP2,4.0,62.21176498925797,0.006,0.8367692307692308,1.0,1.0
positive regulation of translational fidelity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of translational initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of translational termination,15.0,ANB1;HYP2,2.0,62.21176498925797,0.006,0.8367692307692308,1.0,1.0
positive regulation of transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of ubiquitin-dependent endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of ubiquitin-protein transferase activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of vacuole organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of vesicle fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
post-chaperonin tubulin folding pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery,75.0,LRP1;NUP120;NUP133;NUP145;NUP157;NUP60;NUP84;RRP6;SUS1,9.0,18.0,0.001,0.13946153846153847,1.0,1.0
post-translational protein targeting to endoplasmic reticulum membrane,5.0,KAR2;LHS1;MDY2;SEC61;SEC62;SEC63;SEC66;SGT2;SPC2;SSH1;STE24,11.0,126.0,0.001,0.03554901960784314,1.0,1.0
"post-translational protein targeting to membrane, translocation",5.0,KAR2;LHS1;SEC61;SEC62;SEC63;SEC66;SPC2;SSH1;STE24,9.0,132.66554624884907,0.001,0.03554901960784314,1.0,1.0
postreplication repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
potassium ion export across plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
potassium ion import across plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
potassium ion transmembrane transport,9.0,QDR2;SAP185;VCX1;VNX1;YVC1,5.0,102.0,0.001,0.12086666666666668,1.0,1.0
potassium ion transport,9.0,QDR2;SAP185;VCX1;VNX1;YVC1,5.0,102.0,0.001,0.12086666666666668,1.0,1.0
pre-replicative complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pre-replicative complex assembly involved in nuclear cell cycle DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
premeiotic DNA replication,54.0,LGE1;POL1,2.0,24.440336245779918,0.006,0.9065000000000001,1.0,1.0
primary alcohol catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
primary alcohol metabolic process,31.0,ALD4;ALD5;ALD6;PDC1,4.0,81.0,0.001,0.05332352941176471,1.0,1.0
primary cell septum biogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
programmed cell death,42.0,AIM14;BMH1;BMH2;CPR3;FYV10;HXK2;KEX1;NDI1;OYE2;PET9;POR1;STM1;TDH2;TDH3;TIM18,15.0,42.0,0.001,0.20144444444444445,1.0,1.0
proline biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proline catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proline catabolic process to glutamate,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proline metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proline transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proteasomal ubiquitin-independent protein catabolic process,13.0,BLM10;PRE1;PRE10;PRE2;PRE3;PRE4;PRE5;PRE6;PRE7;PRE8;PRE9;PUP1;PUP2;PUP3;SCL1;SSE1;SSE2,17.0,132.0,0.001,0.9065,1.0,1.0
proteasome assembly,13.0,ADD66;BLM10;ECM29;HSC82;HSM3;HSP82;NAS6;PBA1;PNO1;PRE2;PRE4;PRE9;RPN10;RPN11;RPN14;RPN2;RPN6;RPN9;RPT1;RPT2;RPT3;RPT4;RPT5;RPT6;SEM1;UMP1,26.0,132.0,0.001,0.9065,1.0,1.0
proteasome core complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proteasome localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proteasome regulatory particle assembly,12.0,HSM3;NAS6;RPN14;RPT1;RPT2;RPT3;RPT4;RPT5;RPT6,9.0,96.0,0.001,0.09542105263157895,1.0,1.0
proteasome storage granule assembly,12.0,BLM10;PMA1;RPN11;VMA2,4.0,71.0991599877234,0.006,0.5439,1.0,1.0
protein K11-linked ubiquitination,47.0,APC1;APC2;APC4;APC5;DOC1,5.0,36.0,0.001,0.13946153846153847,1.0,1.0
protein K63-linked ubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein N-linked glycosylation via asparagine,5.0,OST1;OST6;STT3;WBP1,4.0,126.0,0.001,0.03554901960784314,0.994,1.0
protein O-linked glycosylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein O-linked mannosylation,5.0,BFR1;DPM1;PMT1;PMT2;PMT4,5.0,126.0,0.001,0.03554901960784314,1.0,1.0
protein acetylation,16.0,ADA2;ARD1;MDM20;NAT1;NAT5,5.0,81.0,0.001,0.226625,1.0,1.0
protein acylation,16.0,ADA2;AKR1;ARD1;MDM20;NAT1;NAT5,6.0,81.0,0.001,0.226625,1.0,1.0
protein autoubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein catabolic process in the vacuole,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein complex oligomerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein deglutathionylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein deglycosylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein deglycosylation involved in glycoprotein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein deneddylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein desumoylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein deubiquitination,39.0,BRE5;RPN11;SUS1;UBP1;UBP3;UBP6;UBP7;UBP9,8.0,45.0,0.001,0.259,0.976,1.0
protein exit from endoplasmic reticulum,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein folding in endoplasmic reticulum,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein histidyl modification to diphthamide,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein import into mitochondrial intermembrane space,2.0,HSP10;HSP60;MIC60;YME1,4.0,117.0,0.001,0.0824090909090909,0.994,1.0
protein import into mitochondrial matrix,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein import into peroxisome matrix,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"protein import into peroxisome matrix, docking",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"protein import into peroxisome matrix, receptor recycling",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein insertion into ER membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein insertion into membrane,15.0,BFR1;HSP104;MDM10;MDY2;MMM1;OXA1;SAM35;SGT2;TIM18;TIM54;TOM22;TOM70;YDJ1,13.0,84.0,0.001,0.20144444444444445,1.0,1.0
protein insertion into mitochondrial inner membrane,15.0,OXA1;TIM18;TIM54;TOM70,4.0,84.0,0.001,0.20144444444444445,1.0,1.0
protein insertion into mitochondrial inner membrane from matrix,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein insertion into mitochondrial membrane,15.0,MDM10;MMM1;OXA1;SAM35;TIM18;TIM54;TOM22;TOM70,8.0,84.0,0.001,0.20144444444444445,1.0,1.0
protein insertion into mitochondrial outer membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to Golgi apparatus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to actin cytoskeleton,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to bud neck,63.0,BCY1;BUD4;CDC11;CHS3;SHS1,5.0,21.0,0.001,0.1133125,1.0,1.0
protein localization to cell cortex,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to cell division site,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to cell division site after cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"protein localization to cell division site involved in cytokinesis, actomyosin contractile ring assembly",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to cell periphery,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to chromatin,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to chromosome,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"protein localization to chromosome, centromeric region",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"protein localization to chromosome, telomeric region",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to condensed chromosome,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to cytoskeleton,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to eisosome filament,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to endoplasmic reticulum exit site,5.0,SEC16;YET1;YET3,3.0,126.0,0.001,0.03554901960784314,1.0,1.0
protein localization to endosome,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to membrane raft,9.0,VAC8,1.0,75.54285748695611,0.006,0.6043333333333334,1.0,1.0
protein localization to microtubule,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to microtubule cytoskeleton,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to microtubule organizing center,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to mitotic spindle pole body,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to nuclear envelope,75.0,MLP1;NUP145;NUP157;NUP170;NUP57,5.0,22.443697499232712,0.001,0.13946153846153847,1.0,1.0
protein localization to nuclear inner membrane,75.0,NUP145;NUP157;NUP170;NUP57,4.0,22.443697499232712,0.001,0.13946153846153847,1.0,1.0
protein localization to nuclear periphery,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to nucleolar rDNA repeats,53.0,RPD3;TOF2,2.0,24.440336245779918,0.006,0.35090322580645167,1.0,1.0
protein localization to phagophore assembly site,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to vacuolar membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein mannosylation,5.0,BFR1;DPM1;MNN5;PMT1;PMT2;PMT4,6.0,126.0,0.001,0.03554901960784314,1.0,1.0
protein maturation by [2Fe-2S] cluster transfer,31.0,GRX5;SSQ1,2.0,81.0,0.001,0.05332352941176471,1.0,1.0
protein maturation by [4Fe-4S] cluster transfer,31.0,GRX5,1.0,81.0,0.001,0.05332352941176471,1.0,1.0
protein maturation by copper ion transfer,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein maturation by iron-sulfur cluster transfer,31.0,GRX5;SSQ1,2.0,81.0,0.001,0.05332352941176471,1.0,1.0
protein methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein modification by small protein removal,39.0,BRE5;KAP95;NUP53;NUP60;PSE1;RPN11;RPN5;RRI2;SUS1;UBP1;UBP3;UBP6;UBP7;UBP9,14.0,45.0,0.001,0.259,0.928,1.0
protein monoubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein neddylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein palmitoylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein polymerization,43.0,ABP1;AIM21;ARC15;ARC18;ARC19;ARC35;ASK1;BNI1;CAP1;CAP2;DAD1;DAD2;DAD3;DAD4;DAM1;DUO1;HSK3;LAS17;NAP1;PFY1;SLA1;SPC110;SPC19;SPC34;SPC98;TDA2;TWF1,27.0,42.0,0.001,0.0824090909090909,1.0,1.0
protein polyubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein processing involved in protein targeting to mitochondrion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein quality control for misfolded or incompletely synthesized proteins,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein refolding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein retention in Golgi apparatus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein stabilization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein sumoylation,55.0,KRE29;NSE3;SMC5;SMC6,4.0,33.0,0.001,0.226625,1.0,1.0
protein targeting to ER,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein targeting to vacuole involved in autophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein unfolding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein urmylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein-DNA complex disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein-RNA complex disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein-RNA complex remodeling,67.0,REA1;RSA4;YTM1,3.0,18.0,0.001,0.6043333333333334,1.0,1.0
protein-containing complex remodeling,67.0,BDP1;BRF1;REA1;ROX3;RSA4;SRB5;SSL2;SUA7;YTM1,9.0,18.0,0.001,0.6043333333333334,1.0,1.0
protein-lipid complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein-lipid complex organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proton export across plasma membrane,56.0,PMA1;PMA2,2.0,22.21848749616356,0.006,1.0,1.0,1.0
proton motive force-driven ATP synthesis,1.0,ATP1;ATP14;ATP15;ATP16;ATP17;ATP18;ATP19;ATP2;ATP20;ATP3;ATP4;ATP5;ATP6;ATP7;TIM11;VMA1,16.0,139.21848749616356,0.006,1.0,0.994,1.0
proton motive force-driven mitochondrial ATP synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proton-transporting two-sector ATPase complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pseudouridine synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pteridine-containing compound biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pteridine-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine nucleobase biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine nucleobase metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine nucleoside bisphosphate biosynthetic process,31.0,CAB3;LAT1;LPD1;PDA1;PDB1;PDX1;SIS2,7.0,81.0,0.001,0.05332352941176471,1.0,1.0
purine nucleoside bisphosphate metabolic process,31.0,CAB3;FAA3;FAA4;HMG1;HMG2;KGD2;LAT1;LPD1;LSC1;LSC2;PDA1;PDB1;PDX1;SIS2;TES1,15.0,81.0,0.001,0.05332352941176471,1.0,1.0
purine nucleoside catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine nucleoside metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine nucleotide catabolic process,34.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,60.0,0.001,0.06475,1.0,1.0
purine nucleotide transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine ribonucleoside catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine ribonucleoside diphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine ribonucleoside diphosphate catabolic process,34.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,60.0,0.001,0.06475,1.0,1.0
purine ribonucleoside diphosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine ribonucleoside metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine ribonucleoside monophosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine ribonucleoside monophosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine ribonucleoside triphosphate biosynthetic process,2.0,ATP1;ATP14;ATP15;ATP16;ATP17;ATP18;ATP19;ATP2;ATP20;ATP3;ATP4;ATP5;ATP6;ATP7;IMD3;IMD4;TIM11;VMA1;YNK1,19.0,117.0,0.001,0.0824090909090909,1.0,1.0
purine ribonucleotide catabolic process,34.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,60.0,0.001,0.06475,1.0,1.0
purine ribonucleotide transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine-containing compound catabolic process,34.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;SAH1;TDH1;TDH2;TDH3;TPI1,18.0,59.221848749616356,0.001,0.06475,1.0,1.0
purine-containing compound transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyridine nucleotide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyridine nucleotide catabolic process,34.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,60.0,0.001,0.06475,1.0,1.0
pyridine-containing compound biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyridine-containing compound catabolic process,34.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,60.0,0.001,0.06475,1.0,1.0
pyridoxal 5'-phosphate salvage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyridoxal phosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyridoxine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyridoxine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine deoxyribonucleoside monophosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine deoxyribonucleoside triphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine deoxyribonucleoside triphosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine deoxyribonucleotide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine nucleobase biosynthetic process,21.0,CPA2;URA4;URA6;URA7,4.0,87.0,0.001,0.15108333333333335,1.0,1.0
pyrimidine nucleobase metabolic process,21.0,CPA2;PHM8;URA4;URA6;URA7,5.0,64.43361373887433,0.006,0.6043333333333334,1.0,1.0
pyrimidine nucleoside diphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine nucleoside diphosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine nucleoside monophosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine nucleoside triphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine nucleoside triphosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine nucleotide biosynthetic process,21.0,CDC21;CPA2;URA4;URA6;URA7;URK1;YNK1,7.0,87.0,0.001,0.15108333333333335,1.0,1.0
pyrimidine nucleotide metabolic process,21.0,CDC21;CPA2;URA4;URA6;URA7;URK1;YNK1,7.0,87.0,0.001,0.15108333333333335,1.0,1.0
pyrimidine ribonucleoside diphosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine ribonucleoside monophosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine ribonucleoside triphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine ribonucleotide biosynthetic process,21.0,CPA2;URA4;URA6;URA7;URK1;YNK1,6.0,87.0,0.001,0.15108333333333335,1.0,1.0
pyrimidine ribonucleotide metabolic process,21.0,CPA2;URA4;URA6;URA7;URK1;YNK1,6.0,87.0,0.001,0.15108333333333335,1.0,1.0
pyrimidine ribonucleotide salvage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine-containing compound biosynthetic process,21.0,CDC21;CPA2;URA4;URA6;URA7;URK1;YNK1,7.0,87.0,0.001,0.15108333333333335,1.0,1.0
pyrimidine-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine-containing compound salvage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyruvate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
quinolinate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
quinolinate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rDNA chromatin condensation,53.0,HMO1;RPD3;SIN3;SMC4;TOF2;YCG1,6.0,33.0,0.001,0.06475,1.0,1.0
rRNA 2'-O-methylation,35.0,SPB1,1.0,53.32436999079255,0.006,1.0,1.0,1.0
rRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rRNA 5'-end processing,49.0,BMS1;BRX1;BUD21;DBP8;DIP2;EMG1;ESF2;FCF1;FCF2;LOC1;MPP10;MRD1;NOC4;NOP14;NOP58;PNO1;PWP2;RCL1;RLP7;ROK1;RRP17;RRP5;RRP9;SAS10;TOM1;UTP10;UTP11;UTP13;UTP14;UTP18;UTP20;UTP23;UTP6;UTP7,34.0,72.0,0.001,0.36260000000000003,0.994,1.0
rRNA acetylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rRNA base methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rRNA catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rRNA export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rRNA pseudouridine synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rRNA transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
re-entry into mitotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
re-entry into mitotic cell cycle after pheromone arrest,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
reactive nitrogen species metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
reactive oxygen species metabolic process,34.0,AHP1;CCP1;CCS1;LPD1;MRP1;RSM26;SOD1;SOD2;TDH2;TDH3;TRR1;TSA1,12.0,57.0,0.001,0.06475,0.964,1.0
receptor metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
receptor-mediated endocytosis,43.0,AKL1;ARC35;CHC1;CMD1;GLC7;HRR25;MYO5;ROD1,8.0,42.0,0.001,0.0824090909090909,1.0,1.0
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
reductive iron assimilation,42.0,AIM14,1.0,31.105882494628986,0.006,0.777,1.0,1.0
regulation of ARF protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ATP-dependent activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of Arp2/3 complex-mediated actin nucleation,43.0,ABP1;ARC40;LAS17;LSB1;MYO3;MYO5;PAN1;SLA1;SLA2;VRP1,10.0,42.0,0.001,0.0824090909090909,1.0,1.0
regulation of COPII vesicle coating,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA damage checkpoint,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA double-strand break processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA replication origin binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA stability,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA-templated DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA-templated DNA replication initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA-templated transcription initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ER to Golgi vesicle-mediated transport,39.0,BRE5;HRR25;TIP20;UBP3,4.0,45.0,0.001,0.259,0.982,1.0
regulation of G1 to G0 transition,54.0,MPT5;RLM1;SSD1,3.0,24.440336245779918,0.006,0.9065000000000001,1.0,1.0
regulation of G1/S transition of mitotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of G2/M transition of mitotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of Golgi organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of IRE1-mediated unfolded protein response,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of MAPK cascade,33.0,AHK1;HOS2;PBS2;SIF2;SNT1,5.0,60.0,0.001,0.10072222222222223,1.0,1.0
regulation of RNA export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of RNA polymerase II transcription preinitiation complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of RNA splicing,62.0,NAM8;RPL30,2.0,21.0,0.001,0.6043333333333334,1.0,1.0
regulation of Ras protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of Rho protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of SNARE complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of TOR signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of TORC1 signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of actin filament bundle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of actin filament depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of actin filament organization,43.0,ABP1;AIM21;ARC15;ARC18;ARC40;BNI1;CAP1;CAP2;EFB1;HOF1;LAS17;LSB1;MYO3;MYO5;PAN1;PFY1;SLA1;SLA2;TDA2;TWF1;VRP1,21.0,42.0,0.001,0.0824090909090909,1.0,1.0
regulation of actin nucleation,43.0,ABP1;ARC40;HOF1;LAS17;LSB1;MYO3;MYO5;PAN1;SLA1;SLA2;VRP1,11.0,42.0,0.001,0.0824090909090909,1.0,1.0
regulation of actin polymerization or depolymerization,43.0,ABP1;AIM21;ARC15;ARC18;BNI1;CAP1;CAP2;LAS17;PFY1;SLA1;TDA2;TWF1,12.0,42.0,0.001,0.0824090909090909,1.0,1.0
regulation of actomyosin contractile ring contraction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of actomyosin structure organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of alcohol biosynthetic process,54.0,MOT3,1.0,24.440336245779918,0.006,0.9065000000000001,1.0,1.0
regulation of anaphase-promoting complex-dependent catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of anatomical structure morphogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of antisense RNA transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of apoptotic process,66.0,BMH1;BMH2;FYV10;HXK2;NDI1;STM1,6.0,13.331092497698137,0.006,1.0,1.0,1.0
regulation of attachment of spindle microtubules to kinetochore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of autophagosome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of autophagy of mitochondrion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of carbohydrate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of carbohydrate catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of carbohydrate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of catalytic activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell adhesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell cycle G2/M phase transition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell cycle checkpoint,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell division,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell morphogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell shape,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell size,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell wall organization or biogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell-cell adhesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cellular amino acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cellular ketone metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cellular respiration,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cellular response to amino acid starvation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cellular response to heat,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of centromere complex assembly,16.0,RIO1,1.0,59.989916239641616,0.006,1.0,1.0,1.0
regulation of chromatin organization,53.0,BDF1;BDF2;CHD1;CTI6;DEP1;ISW1;PHO23;RPD3;RXT2;SAP30;SDS3;SET1;SIN3;WTM1;WTM2,15.0,33.0,0.001,0.06475,1.0,1.0
regulation of clathrin-dependent endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"regulation of cytokinesis, actomyosin contractile ring assembly",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cytokinetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cytoplasmic mRNA processing body assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cytoplasmic translation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cytoplasmic translational initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of dephosphorylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of division septum assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of double-strand break repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of double-strand break repair via homologous recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of double-strand break repair via nonhomologous end joining,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of endoplasmic reticulum unfolded protein response,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ergosterol biosynthetic process,54.0,MOT3,1.0,24.440336245779918,0.006,0.9065000000000001,1.0,1.0
regulation of establishment of protein localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of establishment of protein localization to chromosome,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of exit from mitosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of exocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of fatty acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of filamentous growth,53.0,ASH1;CDC28;DIG1;DIG2;GAL11;KAP123;KSP1;PHO23;RXT2;SAK1;SAP30;SDS3;SFH1;SNF1;SNF2;SNF5;SSN3;STE12;TEC1;UBA4;YTA7,21.0,33.0,0.001,0.06475,1.0,1.0
regulation of filamentous growth of a population of unicellular organisms,53.0,ASH1;DIG1;DIG2;GAL11;KAP123;KSP1;PHO23;RXT2;SAK1;SAP30;SDS3;SFH1;SNF1;SNF2;SNF5;STE12;TEC1;UBA4;YTA7,19.0,33.0,0.001,0.06475,1.0,1.0
regulation of formin-nucleated actin cable assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of fungal-type cell wall organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of generation of precursor metabolites and energy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of gluconeogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of glucose metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of glycogen biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of glycogen catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of glycogen metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of growth of unicellular organism as a thread of attached cells,53.0,ASH1;DIG1;DIG2;GAL11;KAP123;KSP1;PHO23;RXT2;SAK1;SAP30;SDS3;SFH1;SNF1;SNF2;SNF5;STE12;TEC1;UBA4;YTA7,19.0,33.0,0.001,0.06475,1.0,1.0
regulation of heterochromatin organization,53.0,BDF1;BDF2;CTI6;DEP1;PHO23;RPD3;RXT2;SAP30;SDS3;SIN3;WTM1;WTM2,12.0,33.0,0.001,0.06475,1.0,1.0
regulation of hydrolase activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of inorganic anion transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of intracellular pH,9.0,PFK1;PFK2;PMA1;PMA2;RAV1;RAV2;RRG1;SKP1;STV1;VMA1;VMA10;VMA11;VMA13;VMA2;VMA4;VMA5;VMA6;VMA7;VMA8;VPH1;VPS3,21.0,102.0,0.001,0.12086666666666668,1.0,1.0
regulation of intracellular protein transport,5.0,POR1;SCS2;SPC2;STE24,4.0,126.0,0.001,0.03554901960784314,0.994,1.0
regulation of intracellular transport,39.0,ALY2;BRE5;HRR25;ISW1;KAP95;NOG2;NUP145;POR1;REA1;RIO2;SCS2;SGF73;SPC2;STE24;TIP20;UBP3,16.0,33.32773124424534,0.006,1.0,0.946,1.0
regulation of invasive growth in response to glucose limitation,53.0,DIG1;DIG2;GAL11;PHO23;RXT2;SAP30;SDS3;SNF2;SNF5;YTA7,10.0,33.0,0.001,0.06475,1.0,1.0
regulation of lipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of lipid localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of lipid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mRNA 3'-end processing,72.0,NAB2;SPT6,2.0,18.0,0.001,0.13946153846153847,1.0,1.0
regulation of mRNA processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"regulation of mRNA splicing, via spliceosome",62.0,NAM8;RPL30,2.0,21.0,0.001,0.6043333333333334,1.0,1.0
regulation of macroautophagy,68.0,CDC14;CDC55;CTR9;EPL1;ESA1;FAR11;HOG1;IML1;KSP1;NPR2;NPR3;PAF1;PBP1;PIK1;PPG1;PPH21;PPH22;RPD3;RTC1;SIC1;SNF1;TRS33;XRN1;YVH1,24.0,13.331092497698137,0.006,0.6043333333333334,0.994,1.0
regulation of mating type switching,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"regulation of mating-type specific transcription, DNA-templated",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of meiotic DNA double-strand break formation,69.0,MCM21;SET1;SPP1;SWD3;YCG1,5.0,18.0,0.001,0.9065,1.0,1.0
regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of meiotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of meiotic cell cycle phase transition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of meiotic nuclear division,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of membrane lipid distribution,42.0,DNF1;DNF2;DRS2;LEM3;YPK1,5.0,42.0,0.001,0.20144444444444445,1.0,1.0
regulation of metal ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of metaphase/anaphase transition of cell cycle,47.0,APC11;APC5;CDC16;CDC23;CDC55;CTF19;CTF3;DSL1;GAC1;GLC7;MND2;SDS24;SWM1;TPD3,14.0,36.0,0.001,0.13946153846153847,1.0,1.0
regulation of microtubule cytoskeleton organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of microtubule polymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of microtubule polymerization or depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of microtubule-based process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitochondrial DNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitochondrial fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitochondrion organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic actomyosin contractile ring contraction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic cell cycle DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic cell cycle spindle assembly checkpoint,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic cytokinetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic nuclear division,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic recombination,71.0,HST1;RAD3;SSL2;TOP2,4.0,18.0,0.001,0.226625,1.0,1.0
regulation of mitotic sister chromatid segregation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic sister chromatid separation,47.0,APC11;APC5;CDC16;CDC23;CDC55;CTF19;CTF3;DSL1;GAC1;GLC7;MND2;TPD3,12.0,36.0,0.001,0.13946153846153847,1.0,1.0
regulation of mitotic spindle organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic spindle pole body separation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of molecular function,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of monoatomic cation transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of monoatomic ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ncRNA transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of nitrogen utilization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of nuclear cell cycle DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of nuclear-transcribed mRNA poly(A) tail shortening,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of nucleobase-containing compound transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of nucleocytoplasmic transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of nucleotide-excision repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of organelle assembly,68.0,BCY1;CAF20;CDC14;CDC28;CDC39;CDC55;DHH1;HRR25;IML1;NPR2;NPR3;PIK1;PPH21;PPH22;RIO1;SAM1;YVH1,17.0,18.0,0.001,0.10664705882352941,1.0,1.0
regulation of pH,9.0,PFK1;PFK2;PMA1;PMA2;RAV1;RAV2;RRG1;SKP1;STV1;VMA1;VMA10;VMA11;VMA13;VMA2;VMA4;VMA5;VMA6;VMA7;VMA8;VPH1;VPS3,21.0,102.0,0.001,0.12086666666666668,1.0,1.0
regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of phosphate transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of phosphatidylinositol biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of phosphatidylinositol dephosphorylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of phospholipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of phospholipid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of phospholipid translocation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of phosphorylation,63.0,AHK1;ASC1;ASF1;BCY1;CDC11;CDC12;RPP1B;VAC14,8.0,21.0,0.001,0.1133125,1.0,1.0
regulation of polysaccharide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of polysaccharide metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of post-translational protein modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of potassium ion export across plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of programmed cell death,66.0,BMH1;BMH2;FYV10;HXK2;NDI1;STM1,6.0,13.331092497698137,0.006,1.0,1.0,1.0
regulation of proteasomal protein catabolic process,12.0,BLM10;MND2;RPT1;RPT2;RPT3;RPT4;RPT5;RPT6;UBP6,9.0,96.0,0.001,0.09542105263157895,1.0,1.0
regulation of proteasomal ubiquitin-dependent protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein autoubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein catabolic process,12.0,BLM10;MND2;RPN1;RPN2;RPN3;RPT1;RPT2;RPT3;RPT4;RPT5;RPT6;UBP6,12.0,96.0,0.001,0.09542105263157895,1.0,1.0
regulation of protein depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein desumoylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein folding,10.0,ERV2,1.0,86.65210123503789,0.006,0.5439,1.0,1.0
regulation of protein import into nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein kinase C signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein kinase activity,28.0,RPP1B,1.0,46.65882374194348,0.006,1.0,1.0,1.0
regulation of protein localization to cell division site,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein localization to cell division site involved in cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein localization to chromatin,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein localization to nucleolus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein localization to nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein modification by small protein conjugation or removal,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein phosphorylation,63.0,AHK1;ASC1;ASF1;BCY1;CDC11;CDC12;RPP1B,7.0,21.0,0.001,0.1133125,1.0,1.0
regulation of protein polymerization,43.0,ABP1;AIM21;ARC15;ARC18;ASK1;BNI1;CAP1;CAP2;DAD1;DAD2;DAD3;DAD4;DAM1;DUO1;HSK3;LAS17;NAP1;PFY1;SLA1;SPC110;SPC19;SPC34;TDA2;TWF1,24.0,42.0,0.001,0.0824090909090909,1.0,1.0
regulation of protein secretion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein stability,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein ubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein-containing complex disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of proteolysis,12.0,BLM10;MND2;PBI2;PHB1;PHB2;RPT1;RPT2;RPT3;RPT4;RPT5;RPT6;UBP6,12.0,96.0,0.001,0.09542105263157895,1.0,1.0
regulation of proteolysis involved in protein catabolic process,12.0,BLM10;MND2;RPT1;RPT2;RPT3;RPT4;RPT5;RPT6;UBP6,9.0,96.0,0.001,0.09542105263157895,1.0,1.0
regulation of pseudohyphal growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of rDNA heterochromatin formation,53.0,CTI6;DEP1;PHO23;RPD3;RXT2;SAP30;SDS3;SIN3,8.0,33.0,0.001,0.06475,1.0,1.0
regulation of rRNA processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of receptor-mediated endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of reciprocal meiotic recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of response to endoplasmic reticulum stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of response to extracellular stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of response to osmotic stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ribonucleoprotein complex localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ribosomal protein gene transcription by RNA polymerase II,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ribosomal subunit export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of secretion by cell,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of sexual sporulation resulting in formation of a cellular spore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of silent mating-type cassette heterochromatin formation,53.0,BDF1;CTI6;DEP1;PHO23;RPD3;RXT2;SAP30;SDS3;SIN3;WTM1;WTM2,11.0,33.0,0.001,0.06475,1.0,1.0
regulation of sister chromatid cohesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of sister chromatid segregation,47.0,APC1;APC11;APC2;APC5;CDC16;CDC23;CDC27;CDC55;CTF19;CTF3;DSL1;GAC1;GLC7;MND2;SDS24;SWM1;TPD3,17.0,36.0,0.001,0.13946153846153847,1.0,1.0
regulation of small GTPase mediated signal transduction,68.0,BCY1;BEM2;GEA2;GPB2;IML1;IRA1;NET1;NPR3;PXL1;SAC7;TOF2,11.0,18.0,0.001,0.10664705882352941,1.0,1.0
regulation of sphingolipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of spindle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of spindle organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of sporulation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of sporulation resulting in formation of a cellular spore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of stress-activated protein kinase signaling cascade,33.0,HOS2;SIF2;SNT1,3.0,60.0,0.001,0.10072222222222223,1.0,1.0
regulation of telomere maintenance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of telomere maintenance via telomere lengthening,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transcription by RNA polymerase I,53.0,BUD27;CDC14;CDC73;CKA1;CKA2;CKB1;CKB2;CTR9;HMO1;HPR1;LEO1;NAN1;PAF1;PHO23;RIO1;RPD3;RTF1;RXT3;SAP30;SIN3;SNF6;SPT4;SPT5;UME1;UTP10;UTP15;UTP4;UTP5;UTP8;UTP9,30.0,33.0,0.001,0.06475,1.0,1.0
regulation of transcription by RNA polymerase III,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transcription by glucose,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transcription elongation by RNA polymerase II,72.0,ASF1;CAF130;CAF40;CCR4;CDC36;CDC39;CDC73;CET1;ESA1;GCN5;GIM5;KIN28;LEO1;MOT2;NAP1;NOT3;NOT5;NPL3;PAF1;PDP3;PFD1;POP2;RPT4;RPT6;RSC6;RTF1;SPN1;SPT4;SPT5;SPT6;TFG1;VPS15;XRN1;YKE2,34.0,18.0,0.001,0.13946153846153847,1.0,1.0
regulation of transcription from RNA polymerase II promoter by glucose,72.0,SPT6;TUP1;VPS36,3.0,13.331092497698137,0.006,0.4944545454545454,1.0,1.0
regulation of transcription initiation by RNA polymerase II,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transcription regulatory region DNA binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transcription-coupled nucleotide-excision repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transcriptional start site selection at RNA polymerase II promoter,72.0,CHD1;ISW1;SPT6,3.0,18.0,0.001,0.13946153846153847,1.0,1.0
regulation of transferase activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of translational elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of translational fidelity,39.0,CDC60;GCD11;ILS1;NAM2;RPL31A;RPL31B;RPS2;RPS23A;RPS23B;RPS5;RPS9B;SSB1;SSB2;SSZ1;SUI1;VAS1;YHR020W;ZUO1,18.0,57.0,0.001,0.259,1.0,1.0
regulation of translational initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of translational initiation in response to stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of translational termination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transmembrane transport,5.0,PHO87;PHO90;PHO91;RGC1;SAP185;SKS1;SPC2;STE24,8.0,93.31764748388696,0.006,0.19778181818181817,0.994,1.0
regulation of triglyceride metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ubiquitin-dependent protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"regulation of vacuole fusion, non-autophagic",34.0,ENO1;ENO2,2.0,57.0,0.001,0.06475,1.0,1.0
regulation of vacuole organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of vesicle fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of vesicle-mediated transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulatory ncRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulatory ncRNA-mediated gene silencing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
removal of nonhomologous ends,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
replication fork arrest,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
replication fork processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
replication fork progression beyond termination site,44.0,TOP2,1.0,39.99327749309441,0.006,0.518,1.0,1.0
replication-born double-strand break repair via sister chromatid exchange,14.0,ADA2,1.0,84.0,0.001,0.36260000000000003,1.0,1.0
rescue of stalled ribosome,41.0,ASC1;GCN1;RQC1;RQC2;SLH1,5.0,42.0,0.001,0.45325,1.0,1.0
resolution of DNA recombination intermediates,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
resolution of meiotic recombination intermediates,44.0,TOP2,1.0,39.99327749309441,0.006,0.518,1.0,1.0
respiratory electron transport chain,2.0,CIR2;COX1;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8;CYT1;NDI1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1;SDH1;SDH2,20.0,117.0,0.001,0.0824090909090909,0.958,1.0
response to DNA integrity checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to acid chemical,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to alcohol,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to amino acid,54.0,KOG1,1.0,24.440336245779918,0.006,0.9065000000000001,1.0,1.0
response to antibiotic,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to arsenic-containing substance,15.0,CUZ1;MET30;MET4;TIM18,4.0,84.0,0.001,0.20144444444444445,1.0,1.0
response to cadmium ion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to carbohydrate,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to cell cycle checkpoint signaling,75.0,HRP1;MLP1;NUP53,3.0,13.331092497698137,0.006,0.6398823529411765,1.0,1.0
response to cycloheximide,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to furfural,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to heat,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to hydrogen peroxide,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to inorganic substance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to light stimulus,38.0,RSC2,1.0,48.880672491559835,0.006,0.8367692307692308,1.0,1.0
response to metal ion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to monosaccharide,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to organic cyclic compound,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to radiation,38.0,RSC2,1.0,48.880672491559835,0.006,0.8367692307692308,1.0,1.0
response to reactive oxygen species,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to salt stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to spindle checkpoint signaling,75.0,MLP1;NUP53,2.0,13.331092497698137,0.006,0.6398823529411765,1.0,1.0
response to temperature stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to unfolded protein,5.0,GLC7;HRD1;HSP60;IRE1;ISW1;KAR2;KIN2;LHS1;PMT1;PMT2;PMT4;REG1;SCJ1;SNF1;SPT20;YOS9;YPT1;ZIM17,18.0,93.31764748388696,0.006,0.19778181818181817,0.97,1.0
response to xenobiotic stimulus,67.0,AFG2;NPR2;PDR1;PDR15;PDR16;PDR5;RDS3;ROD1,8.0,13.331092497698137,0.006,1.0,1.0,1.0
reticulophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"retrograde protein transport, ER to cytosol",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"retrograde transport, endosome to Golgi",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"retrograde transport, vesicle recycling within Golgi",78.0,COG1;COG3;COG4,3.0,18.0,0.001,0.9065,1.0,1.0
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
retrotransposon silencing,70.0,ELG1;RTT107,2.0,18.0,0.001,0.20144444444444445,1.0,1.0
ribonucleoprotein complex localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleoside catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleoside diphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleoside diphosphate catabolic process,34.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,60.0,0.001,0.06475,1.0,1.0
ribonucleoside diphosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleoside metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleoside monophosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleoside monophosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleoside triphosphate biosynthetic process,2.0,ATP1;ATP14;ATP15;ATP16;ATP17;ATP18;ATP19;ATP2;ATP20;ATP3;ATP4;ATP5;ATP6;ATP7;CPA2;IMD3;IMD4;TIM11;URA7;URK1;VMA1;YNK1,22.0,117.0,0.001,0.0824090909090909,1.0,1.0
ribonucleotide catabolic process,34.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,60.0,0.001,0.06475,1.0,1.0
ribophagy,39.0,BRE5;CDC48;UBP3;VAC8,4.0,45.0,0.001,0.259,0.988,1.0
ribosomal large subunit assembly,82.0,BRX1;DRS1;IPI1;IPI3;LSG1;MAK11;MAK21;MRH4;MRT4;NOP53;REA1;REX4;RIX1;RPF2;RPL10;RPL11A;RPL11B;RPL12A;RPL12B;RPL14A;RPL14B;RPL25;RPL3;RPL33A;RPL40A;RPL40B;RPL5;RPL6A;RPL6B;RPP0;RRP5;RSA3;RSA4;SPB4;SQT1;SSF1;SSF2;YVH1,38.0,252.0,0.001,0.9065,1.0,1.0
ribosomal large subunit export from nucleus,41.0,ARX1;BCP1;BUD20;CRM1;ECM1;JJJ1;LOC1;MEX67;MRT4;MTR2;NIC96;NMD3;NOG2;NOP53;NSP1;NUG1;NUP120;NUP85;REA1;RIX7;RPF1;RPL1A;RPL1B;RPL40A;RPL40B;RRS1;SDA1;YVH1,28.0,42.0,0.001,0.45325,1.0,1.0
ribosomal small subunit assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribosomal small subunit export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribosome disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribosome-associated ubiquitin-dependent protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
second-messenger-mediated signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
secondary alcohol biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
secondary alcohol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
secondary metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
septin cytoskeleton organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
septin ring assembly,63.0,BNI5;CBF2;CDC10;CDC12;CDC3;GIN4;SHS1;SKP1,8.0,21.0,0.001,0.1133125,1.0,1.0
septin ring disassembly,63.0,CDC3,1.0,15.552941247314493,0.006,0.6398823529411765,1.0,1.0
septin ring organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
septum digestion after cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sequestering of actin monomers,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
serine family amino acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
serine family amino acid catabolic process,31.0,CHA1;ILV1;LPD1;SHM1;SHM2,5.0,59.989916239641616,0.006,0.2529767441860465,1.0,1.0
serine family amino acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
serine import across plasma membrane,42.0,GNP1,1.0,31.105882494628986,0.006,0.777,1.0,1.0
serine transport,42.0,GNP1,1.0,31.105882494628986,0.006,0.777,1.0,1.0
siderophore transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
signal peptide processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
signal transduction in response to DNA damage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
signal transduction involved in filamentous growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
signal transduction involved in positive regulation of conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
single-species surface biofilm formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sister chromatid biorientation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
small nucleolar ribonucleoprotein complex assembly,59.0,HSC82;HSP82;NHP2;PIH1;RVB1;RVB2,6.0,24.0,0.001,0.9065,1.0,1.0
small-subunit processome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
snRNA 3'-end processing,48.0,LRP1;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,11.0,63.99327749309441,0.001,0.06714814814814815,0.994,1.0
snRNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
snRNA modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
snRNA processing,48.0,LRP1;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SEN1;SKI6,12.0,63.99327749309441,0.001,0.06714814814814815,0.994,1.0
snRNA pseudouridine synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sno(s)RNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sno(s)RNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sno(s)RNA processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sno(s)RNA transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
snoRNA guided rRNA pseudouridine synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
snoRNA localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
snoRNA splicing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
snoRNA transcription by RNA polymerase II,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sodium ion transmembrane transport,9.0,VNX1;YVC1,2.0,102.0,0.001,0.12086666666666668,1.0,1.0
sphingoid long-chain base transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sphingoid metabolic process,5.0,LCB1;LCB2;LCB5;TIM54,4.0,126.0,0.001,0.03554901960784314,1.0,1.0
sphingolipid biosynthetic process,5.0,AUR1;ELO3;FLC1;FLC2;IFA38;LAC1;LAG1;LCB1;LCB2;LCB5;LIP1;NPR1;SEI1;TIM54;YPK1,15.0,132.66554624884907,0.001,0.03554901960784314,1.0,1.0
sphingosine biosynthetic process,5.0,LCB1;LCB2;LCB5;TIM54,4.0,126.0,0.001,0.03554901960784314,1.0,1.0
spindle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spindle disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spindle elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spindle pole body duplication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spindle pole body organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spliceosomal complex assembly,26.0,CDC40;CLF1;CUS1;EXO84;HSH155;IST3;ISY1;LUC7;NAM8;PRP11;PRP39;PRP42;PRP8;PRP9;RDS3;RSE1;SPT5;YHC1,18.0,153.0,0.001,0.259,1.0,1.0
spliceosomal complex disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spliceosomal conformational changes to generate catalytic conformation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spliceosomal snRNP assembly,24.0,LSM4;PRP3;PRP31;PRP6;PRP8;SMD1;SMD2;SMD3;SME1;SMX2;SMX3;SNU114;YHC1,13.0,99.0,0.001,0.6043333333333334,1.0,1.0
spliceosomal tri-snRNP complex assembly,23.0,PRP31;PRP6;PRP8;SNU114,4.0,75.0,0.001,0.20144444444444445,1.0,1.0
spliceosome conformational change to release U4 (or U4atac) and U1 (or U11),23.0,BRR2;PRP38;SNU114,3.0,75.0,0.001,0.20144444444444445,1.0,1.0
steroid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sterol biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sterol homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sterol import,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sterol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sterol transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
stress granule assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
stress granule disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
stress-activated protein kinase signaling cascade,33.0,HOG1;HOS2;PBS2;SIF2;SNT1,5.0,60.0,0.001,0.10072222222222223,1.0,1.0
stress-induced homeostatically regulated protein degradation pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sulfate assimilation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sulfur amino acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sulfur amino acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sulfur compound catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sulfur compound transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
synaptonemal complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
synaptonemal complex organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA 5'-end processing,64.0,GEP5;POP1;POP4;POP5;POP7;PSP2;RPM2;RRG1;RRG8,9.0,21.0,0.001,0.36260000000000003,1.0,1.0
tRNA 5'-leader removal,64.0,POP1;POP4;POP5;POP7;PSP2;RPM2,6.0,25.0,0.001,0.36260000000000003,1.0,1.0
tRNA aminoacylation for mitochondrial protein translation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA aminoacylation for protein translation,15.0,ARC1;CDC60;CRS1;DED81;DPS1;GLN4;GRS1;GUS1;HTS1;ILS1;KRS1;MES1;MSK1;NAM2;SES1;SLM5;THS1;TYS1;VAS1;YDR341C;YHR020W,21.0,84.0,0.001,0.20144444444444445,1.0,1.0
tRNA catabolic process,48.0,AIR2;CSL4;DIS3;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6;XRN1,14.0,63.99327749309441,0.001,0.06714814814814815,0.982,1.0
tRNA export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA gene clustering,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA import into nucleus,65.0,SIS1;SSA2;YDJ1,3.0,21.0,0.001,0.1295,1.0,1.0
tRNA methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA nucleoside ribose methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA re-export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"tRNA splicing, via endonucleolytic cleavage and ligation",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA thio-modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA threonylcarbamoyladenosine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA threonylcarbamoyladenosine modification,61.0,BUD32;KAE1,2.0,15.552941247314493,0.006,1.0,1.0,1.0
tRNA transcription by RNA polymerase III,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation,40.0,ELP3;IKI3,2.0,42.0,0.001,0.6043333333333334,1.0,1.0
tRNA wobble base modification,40.0,CBR1;ELP2;ELP3;ELP4;HRR25;IKI1;IKI3;ISU1;KTI11;NFS1;SAP185;SIT4;UBA4,13.0,42.0,0.001,0.6043333333333334,1.0,1.0
tRNA wobble position uridine thiolation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA wobble uridine modification,40.0,CBR1;ELP2;ELP3;ELP4;HRR25;IKI1;IKI3;ISU1;KTI11;NFS1;SAP185;SIT4;UBA4,13.0,42.0,0.001,0.6043333333333334,1.0,1.0
telomere capping,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
telomere localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
telomere maintenance via recombination,61.0,BRE1;BUD32;IES3;IES4;IES5;INO80;KAE1;NHP10;RFA1;RFA2;RFA3;TOP2;YLL066C;YML133C;YRF1-2;YRF1-3;YRF1-6;YRF1-7,18.0,21.0,0.001,1.0,1.0,1.0
telomere maintenance via telomerase,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
telomere maintenance via telomere lengthening,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
telomere tethering at nuclear periphery,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
termination of RNA polymerase I transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
termination of RNA polymerase II transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"termination of RNA polymerase II transcription, exosome-dependent",52.0,PCF11;PTI1;SSU72,3.0,33.0,0.001,0.13946153846153847,1.0,1.0
"termination of RNA polymerase II transcription, poly(A)-coupled",52.0,NPL3;PCF11;PTA1;RAI1;REF2;SSU72,6.0,33.0,0.001,0.13946153846153847,1.0,1.0
termination of RNA polymerase III transcription,72.0,RPC11;SEN1,2.0,13.331092497698137,0.006,0.4944545454545454,1.0,1.0
tetrahydrobiopterin biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tetrahydrofolate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tetrahydrofolate interconversion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tetrahydrofolate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
thioester biosynthetic process,31.0,LAT1;LPD1;PDA1;PDB1;PDX1,5.0,81.0,0.001,0.05332352941176471,1.0,1.0
thioester metabolic process,31.0,FAA3;FAA4;KGD2;LAT1;LPD1;LSC1;LSC2;PDA1;PDB1;PDX1;TES1,11.0,81.0,0.001,0.05332352941176471,1.0,1.0
threonine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
threonine catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
threonine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcription antitermination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcription by RNA polymerase III,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcription elongation by RNA polymerase I,6.0,BUD27;CDC73;CTR9;HPR1;LEO1;PAF1;RPA34;RPA49;RTF1;SPT4;SPT5,11.0,123.0,0.001,0.1648181818181818,1.0,1.0
transcription elongation-coupled chromatin remodeling,72.0,HIR2;SPT5,2.0,13.331092497698137,0.006,0.4944545454545454,1.0,1.0
transcription initiation at RNA polymerase I promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcription initiation at RNA polymerase III promoter,6.0,BDP1;BRF1;RPC17;RPC25;RPC31;SPT15;TFC1;TFC3,8.0,123.0,0.001,0.1648181818181818,1.0,1.0
transcription open complex formation at RNA polymerase II promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcription preinitiation complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcription-coupled nucleotide-excision repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,75.0,LRP1;NUP120;NUP133;NUP145;NUP157;NUP170;NUP60;NUP84;RRP6;SUS1,10.0,22.443697499232712,0.001,0.13946153846153847,1.0,1.0
transcriptional start site selection at RNA polymerase II promoter,72.0,CHD1;HMO1;ISW1;SPT6;SSL2;SSU72;SUA7;TFG1;TFG2,9.0,18.0,0.001,0.13946153846153847,1.0,1.0
translation reinitiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
translational frameshifting,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
translational termination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
translesion synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transsulfuration,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
trehalose biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
trehalose catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
trehalose metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
trehalose metabolism in response to stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tricarboxylic acid cycle,31.0,ACO1;FUM1;IDH1;IDH2;IDP1;KGD1;KGD2;LSC1;LSC2;LYS12;MDH1;MDH2;MLS1;SDH1;SDH2,15.0,81.0,0.001,0.05332352941176471,1.0,1.0
tricarboxylic acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
triglyceride catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
triglyceride homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
triglyceride metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tubulin complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tyrosine transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ubiquinone biosynthetic process,31.0,CAT5;COQ3;COQ5,3.0,81.0,0.001,0.05332352941176471,1.0,1.0
ubiquitin-dependent endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ubiquitin-dependent glycoprotein ERAD pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ubiquitin-dependent protein catabolic process via the N-end rule pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
urea cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
urea metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vacuolar protein processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vacuolar proton-transporting V-type ATPase complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vacuolar transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vacuole fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"vacuole fusion, non-autophagic",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vacuole inheritance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
valine catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
valine metabolic process,31.0,BAT1;BAT2;EHD3;ILV2;ILV3;ILV5;ILV6;LPD1,8.0,81.0,0.001,0.05332352941176471,1.0,1.0
very long-chain fatty acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
very long-chain fatty acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle budding from membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle cargo loading,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle coating,55.0,GLO3;SEC16;SEC23;SEC28,4.0,33.0,0.001,0.226625,1.0,1.0
vesicle cytoskeletal trafficking,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle docking,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle docking involved in exocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle fusion to plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle fusion with Golgi apparatus,10.0,BOS1;HRR25;SEC17;SEC18;SEC22;SLY1;YIP1,7.0,117.0,0.001,0.1133125,1.0,1.0
vesicle fusion with vacuole,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"vesicle targeting, rough ER to cis-Golgi",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"vesicle targeting, to, from or within Golgi",55.0,GLO3;SEC16;SEC23,3.0,24.440336245779918,0.006,1.0,1.0,1.0
vesicle tethering involved in exocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle transport along actin filament,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vitamin B6 biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vitamin B6 metabolic process,21.0,BUD17;PDX3;YBL036C,3.0,87.0,0.001,0.15108333333333335,1.0,1.0
vitamin transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
wobble position ribose methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
wybutosine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
xenobiotic detoxification by transmembrane export across the plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
xenobiotic transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
zinc ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
